<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">69207</article-id><article-id pub-id-type="doi">10.7554/eLife.69207</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Protective mitochondrial fission induced by stress-responsive protein GJA1-20k</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-234696"><name><surname>Shimura</surname><given-names>Daisuke</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9954-2162</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-234697"><name><surname>Nuebel</surname><given-names>Esther</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-234698"><name><surname>Baum</surname><given-names>Rachel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250380"><name><surname>Valdez</surname><given-names>Steven E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234699"><name><surname>Xiao</surname><given-names>Shaohua</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-234695"><name><surname>Warren</surname><given-names>Junco S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-250381"><name><surname>Palatinus</surname><given-names>Joseph A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234700"><name><surname>Hong</surname><given-names>TingTing</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-162288"><name><surname>Rutter</surname><given-names>Jared</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2710-9765</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-233668"><name><surname>Shaw</surname><given-names>Robin M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7429-6092</contrib-id><email>Robin.Shaw@hsc.utah.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah</institution><addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Howard Hughes Medical Institute, University of Utah</institution><addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Biochemistry, University of Utah</institution><addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Biomedical Sciences, Noorda College of Osteopathic Medicine</institution><addr-line><named-content content-type="city">Provo</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Department of Neurology, University of California at Los Angeles</institution><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Diabetes and Metabolism Research Center, University of Utah</institution><addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>Department of Pharmacology and Toxicology, College of Pharmacy, University of Utah</institution><addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Johnson</surname><given-names>Simon C</given-names></name><role>Reviewing Editor</role><aff><institution>University of Washington</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kaeberlein</surname><given-names>Matt</given-names></name><role>Senior Editor</role><aff><institution>University of Washington</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>05</day><month>10</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e69207</elocation-id><history><date date-type="received" iso-8601-date="2021-04-08"><day>08</day><month>04</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-09-09"><day>09</day><month>09</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-05-05"><day>05</day><month>05</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.05.05.442750"/></event></pub-history><permissions><copyright-statement>© 2021, Shimura et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Shimura et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-69207-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-69207-figures-v1.pdf"/><abstract><p>The Connexin43 gap junction gene <italic>GJA1</italic> has one coding exon, but its mRNA undergoes internal translation to generate N-terminal truncated isoforms of Connexin43 with the predominant isoform being only 20 kDa in size (GJA1-20k). Endogenous GJA1-20k protein is not membrane bound and has been found to increase in response to ischemic stress, localize to mitochondria, and mimic ischemic preconditioning protection in the heart. However, it is not known how GJA1-20k benefits mitochondria to provide this protection. Here, using human cells and mice, we identify that GJA1-20k polymerizes actin around mitochondria which induces focal constriction sites. Mitochondrial fission events occur within about 45 s of GJA1-20k recruitment of actin. Interestingly, GJA1-20k mediated fission is independent of canonical Dynamin-Related Protein 1 (DRP1). We find that GJA1-20k-induced smaller mitochondria have decreased reactive oxygen species (ROS) generation and, in hearts, provide potent protection against ischemia-reperfusion injury. The results indicate that stress responsive internally translated GJA1-20k stabilizes polymerized actin filaments to stimulate non-canonical mitochondrial fission which limits ischemic-reperfusion induced myocardial infarction.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>GJA1-20k</kwd><kwd>mitochondria</kwd><kwd>actin dynamics</kwd><kwd>mitochondria dynamics</kwd><kwd>ischemia/reperfusion</kwd><kwd>organ protection</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01HL094414</award-id><principal-award-recipient><name><surname>Shaw</surname><given-names>Robin Mark</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01HL138577</award-id><principal-award-recipient><name><surname>Shaw</surname><given-names>Robin Mark</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM131845</award-id><principal-award-recipient><name><surname>Rutter</surname><given-names>Jared</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01HL133286</award-id><principal-award-recipient><name><surname>Hong</surname><given-names>Tingting</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Stress-induced alternative translation of an otherwise common gap junction protein generates an isoform that orchestrates protective mitochondrial fission and organ protection during anticipated ischemia.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Ischemia-Reperfusion (I/R) injury is known to induce excessive reactive oxygen species (ROS) in mitochondria, which results in cellular dysfunction and organ damage. Interestingly, the phenomenon of ischemic preconditioning, first described 35 years ago (<xref ref-type="bibr" rid="bib38">Murry et al., 1986</xref>), is a potent yet ironic protection of organs from ischemia-induced damage achieved by preceding the full ischemic insult with shorter bouts of ischemia. Despite the large therapeutic potential of preconditioning for any organ such as heart, kidney, skeletal muscle, or brain subjected to anticipated ischemia, the mechanisms of preconditioning are not well understood, nor has an intervention been identified to successfully translate the phenomenon into clinical utility (<xref ref-type="bibr" rid="bib28">Heusch and Gersh, 2020</xref>).</p><p>Related to preconditioning is the perplexing dynamic regulation of mitochondria itself. Mitochondria undergo both fission and fusion in an adaptive equilibrium which directly affects cellular activity and response to stress (<xref ref-type="bibr" rid="bib65">Youle and van der Bliek, 2012</xref>; <xref ref-type="bibr" rid="bib17">Friedman and Nunnari, 2014</xref>). It is not clear if an overall shift to fission or fusion is sufficient to define mitochondrial fidelity, or whether a change in the fission-fusion equilibrium occurs secondary to multiple distinct pathways which could be either beneficial or harmful, depending on the pathway taken. For instance, is mitochondrial fission a causative element of ROS generation, apoptosis, cellular senescence, and cell death (<xref ref-type="bibr" rid="bib56">Suen et al., 2008</xref>; <xref ref-type="bibr" rid="bib61">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Nishimura et al., 2018</xref>), or is fission actually protective, such as by promoting mitophagy which can promote survival (<xref ref-type="bibr" rid="bib51">Shirakabe et al., 2016</xref>; <xref ref-type="bibr" rid="bib9">Burman et al., 2017</xref>)? The nuance in understanding the context of mitochondrial fission helps explain the complex relationship between mitochondrial morphology and function (<xref ref-type="bibr" rid="bib40">Nunnari and Suomalainen, 2012</xref>; <xref ref-type="bibr" rid="bib42">Picard et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Song et al., 2015</xref>). If we have a better understanding of conditions in which mitochondrial fission results from a protective mechanism, we will be closer to learning how to preserve mitochondrial fidelity in the setting of ischemic and reperfusion stress.</p><p>Both the gap junction protein Connexin43 (Cx43) and mitochondria are associated with preconditioning protection (<xref ref-type="bibr" rid="bib21">Garcia-Dorado et al., 2006</xref>; <xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Rodriguez-Sinovas et al., 2018</xref>). Little is known how the gap junction channel and organelle convey protection during preconditioning. <italic>GJA1</italic>, which encodes Cx43, has a single coding exon and thus is not subject to splicing (<xref ref-type="bibr" rid="bib52">Smyth and Shaw, 2013</xref>). However, <italic>GJA1</italic> mRNA is subject to endogenous internal translation generating several N-terminal truncated isoforms (<xref ref-type="bibr" rid="bib52">Smyth and Shaw, 2013</xref>; <xref ref-type="bibr" rid="bib47">Salat-Canela, 2014</xref>; <xref ref-type="bibr" rid="bib59">Ul-Hussain et al., 2014</xref>). GJA1-20k, which contains the full Cx43 C-terminus but lacks transmembrane domains, is the most abundant and most common smaller isoform and is essential to full-length Cx43 trafficking (<xref ref-type="bibr" rid="bib52">Smyth and Shaw, 2013</xref>; <xref ref-type="bibr" rid="bib63">Xiao et al., 2020</xref>) by recruiting cytoplasmic actin to organize trafficking pathways (<xref ref-type="bibr" rid="bib3">Basheer et al., 2017</xref>). In addition, GJA1-20k is highly enriched at the outer mitochondrial membrane (<xref ref-type="bibr" rid="bib18">Fu et al., 2017</xref>; <xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>). GJA1-20k abundance increases with hypoxic and ischemic stress (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>), resulting in a phenotypically profound cardiac protection that mimics ischemic preconditioning (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>; <xref ref-type="bibr" rid="bib62">Wang et al., 2019</xref>). It is not known how GJA1-20k protects mitochondria during stress.</p><p>In the present study, we found an inverse relationship between the presence of GJA1-20k and mitochondria size in cultured cells and mice. This relationship is not affected by typical mediators of mitochondrial dynamics by Dynamin Related Protein 1 (DRP1), but rather is strongly dependent on actin dynamics. With the generation of smaller actin-associated mitochondria, we observed decreased oxygen consumption, decreased ROS generation, and profound protection against ischemia-reperfusion damage. Our data demonstrate a novel non-canonical mechanism of protective mitochondrial fission which is dependent on GJA1-20k and cytoskeletal dynamics. The findings also identify GJA1-20k as a pharmaceutical candidate for protection of organs undergoing anticipated ischemia.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>GJA1-20k induces mitochondrial fission in vitro and in vivo</title><p>To understand the interplay between GJA1-20k and mitochondria, we expressed GJA1-20k in HEK293 cells and analyzed mitochondrial morphology by fluorescence imaging. GJA1-20k co-localizes with mitochondria and its presence results in a more rounded and punctate appearance of the mitochondria. GJA1-20k also induces a 54% decrease in average mitochondrial area (<xref ref-type="fig" rid="fig1">Figure 1A and F</xref>). siRNA-mediated knock-down of <italic>GJA1</italic> expression (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>) conversely increases mitochondrial area by 20% (<xref ref-type="fig" rid="fig1">Figure 1B and F</xref>). Furthermore, mitochondrial size after <italic>GJA1</italic> knock-down can be rescued by siRNA-resistant GJA1-20k overexpression, but not with overexpression of siRNA resistant Cx43-M6L, which expresses full-length Cx43 without the truncated isoforms (<xref ref-type="bibr" rid="bib52">Smyth and Shaw, 2013</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B, C</xref>). Together, these data suggest that the short GJA1-20k isoform, but not full-length Cx43, reduces mitochondrial size.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>GJA1-20k decreases in mitochondrial size.</title><p>(<bold>A</bold>–<bold>C</bold>) Representative live cell images of mitochondria in HEK293 (<bold>A</bold>, GST- or GJA1-20k-transfected; <bold>B</bold>, Control and siGja1) and mouse neonatal cardiomyocytes (<bold>C</bold>, WT, GJA1-20k-transducted, and Gja1<sup>M213L/M213L</sup>). The right-most panels are magnified images. (<bold>D</bold>) and (<bold>E</bold>) Representative EM images from young mouse hearts (<bold>D</bold>, WT or Gja1<sup>M213L/M213L</sup>) and adult mouse hearts (<bold>E</bold>, GST- or GJA1-20k-injected). (<bold>F</bold>) Summary of the fold change in the average area of mitochondria. (n = 51 (GST), 67 (GJA1-20k), 52 (Control), or 57 (siGja1) HEK293) cells from five independent experiments; n = 46 (WT), 47 (GJA1-20k), or 48 (Gja1<sup>M213L/M213L</sup>) cells from four hearts; n = 84 (WT) or 91 (Gja1<sup>M213L/M213L</sup>) images from six hearts; n = 25 (GST), or 28 (GJA1-20k) images from three hearts. Graphs were expressed as mean ± SD (HEK293) or± SEM (mouse). p values were determined by two-tailed Mann-Whitney U-test or Kruskal-Wallis test with Dunn’s post-hoc test. **p &lt; 0.01, ***p &lt; 0.001. Scale bars, 10 μm and 5 μm in magnified (<bold>A–C</bold>); 2 μm (<bold>D and E</bold>). Exact p values and statistical data are provided in the source data.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>All data points of the mitochondrial size and the statistical data for <xref ref-type="fig" rid="fig1">Figure 1F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69207-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>The confirmation of Gja1 knock-down and the mitochondrial morphology rescued by GJA1-20k.</title><p>(<bold>A</bold>) Western blot analysis for Gja1 knock-down by siRNA. Tubulin was used as internal loading control. n = 3 independent experimental repeats. (<bold>B</bold>) The representative confocal live cell imaging of Gja1 knocked-down HEK293 cells with Cx43-M6L or GJA1-20k transfection. (<bold>C</bold>) The fold change in the average area of individual mitochondria. n = 52 (Control), 57 (siGja1), 60 (siGja1+ M6 L), or 64 (siGja1+ GJA1-20 k) cells from five independent experiments. The images and the values of Control and siGja1 are also shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. (<bold>D</bold>) The representative live cell imaging of mitochondria in WT mouse neonatal CMs with adenovirus-mediated GFP induction. The right panel indicates magnified image surrounded by square. (<bold>E</bold>) The fold change in the average area of individual mitochondria between WT (no virus introduction, the image and the value shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>) and GFP-V5 introduction. n = 46 (WT) or 35 (GFP) cells from four hearts. Graphs were expressed as mean ± SD (<bold>C</bold>) or SEM (<bold>E</bold>). p values were determined by two-tailed Mann-Whitney U-test or Kruskal-Wallis test with Dunn’s post-hoc test. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001; n.s., not significant. Scale bars, 10 μm or 5 μm in magnified image. Exact p values and statistical data are provided in the source data.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>All data points of the mitochondrial size and the statistical data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69207-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>The effects of GJA1-20k on membrane potential, ATP production, mitochondrial biogenesis, and mitophagy.</title><p>(<bold>A</bold>) TMRE intensity (mitochondrial membrane potential) in HEK293 cells with GST or GJA1-20k transfection. n = 39 (GST) or 41 (GJA1-20k) cells from three independent experiments. (<bold>B</bold>) ATP production from HEK293 cells with GST or GJA1-20k transfection. n = 10 replicates. (<bold>C</bold>) The fold change in mitochondrial DNA copy number in HEK293 or mouse heart with or without the modification of GJA1-20k expression. n = 5 independent experimental repeats (HEK293); n = 5 (WT), or 6 (Gja1<sup>M213L/M213L</sup>) hearts; or 10 (AAV9-induced-GST or GJA1-20k) hearts. (<bold>D</bold>) and (<bold>F</bold>) Western blot analysis for mitochondrial biogenesis and mitophagy marker proteins in HEK293 cells (<bold>D</bold>) or mouse hearts (<bold>F</bold>). Tubulin was used as internal loading control. (<bold>E</bold>) and (<bold>G</bold>) The fold change of the level of the proteins and ratio of LC3-ii/-i in HEK293 cells (<bold>E</bold>) or mouse hearts (<bold>G</bold>). n = 5 independent experimental repeats (HEK293 cells); 4 (LC3) or five hearts from WT or Gja1<sup>M213L/M213L</sup> mouse. Graphs were expressed as mean ± SD (HEK293) or SEM (mouse). p values were determined by two-tailed Mann-Whitney U-test. *p &lt; 0.05, **p &lt; 0.01; n.s., not significant. Exact p values and statistical data are provided in the source data.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>All data points of the intensity of TMRE, ATP amount, mitochondria DNA copy number, and the protein expression levels and the statistical data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69207-fig1-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-fig1-figsupp2-v1.tif"/></fig></fig-group><p>Since GJA1-20k is abundantly expressed in cardiomyocytes (CMs) suggesting an important function in heart (<xref ref-type="bibr" rid="bib52">Smyth and Shaw, 2013</xref>; <xref ref-type="bibr" rid="bib63">Xiao et al., 2020</xref>), and GJA1-20k can convey ischemic preconditioning protection in heart (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>) we used cardiomyocytes as a primary cell model to explore GJA1-20k function. We overexpressed GJA1-20k by adenovirus transduction in wild type (WT) neonatal mouse CMs and found a decrease in the average mitochondria area (<xref ref-type="fig" rid="fig1">Figure 1C and F</xref>). We then used neonatal CMs from a <italic>Gja1<sup>M213L/M213L</sup></italic> mouse line that was recently generated by mutating the internal AUG (Methionine) at residue 213 of <italic>Gja1</italic> to UUA (Leucine). This M213L mutation removes the internal translation start site, resulting in expression of full length Cx43 protein but not the internally translated GJA1-20k isoform (<xref ref-type="bibr" rid="bib63">Xiao et al., 2020</xref>). Neonatal CMs from <italic>Gja1<sup>M213L/M213L</sup></italic> mice have an increase in their average area of mitochondria (<xref ref-type="fig" rid="fig1">Figure 1C and F</xref>), in contrast to the decrease in mitochondrial area of neonatal CMs with GJA1-20k overexpression (<xref ref-type="fig" rid="fig1">Figure 1C and F</xref>). Thus, both cultured cells and neonatal mouse cardiomyocytes exhibit an inverse relationship between the presence of GJA1-20k and mitochondrial size.</p><p>The homozygous <italic>Gja1<sup>M213L/M213L</sup></italic> mice, which lack the expression of GJA1-20k but not full-length Cx43, die from poor gap junction trafficking and arrhythmogenic sudden cardiac death two to four weeks after birth (<xref ref-type="bibr" rid="bib63">Xiao et al., 2020</xref>). We therefore pre-emptively sacrificed and examined two-week old homozygous <italic>Gja1<sup>M213L/M213L</sup></italic> mice, and explored mitochondrial size by electron microscopy (EM). The mitochondria of 2-week-old cardiomyocytes deficient of GJA1-20k are enlarged (<xref ref-type="fig" rid="fig1">Figure 1D and F</xref>). We then delivered exogenous GJA1-20k using adeno-associated virus type 9 (AAV9) to 8 week old adult WT mice (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>) and found a decrease in the average mitochondrial area (<xref ref-type="fig" rid="fig1">Figure 1E and F</xref>). Taken together, in cell lines, neonatal CM, young mouse hearts, and mature mouse hearts, an increase in GJA1-20k results in smaller mitochondria, whereas a decrease in GJA1-20k results in larger mitochondria. Previously, we reported that GJA1-20k is involved in mitochondrial biogenesis (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>). Consistent with our previous study, AAV9-transduced adult cardiomyocytes showed increased mitochondrial DNA copy number and GJA1-20k deficient mice (Gja1<sup>M213L/M213L</sup>) had decreased copy number. However, exogenous GJA1-20k did not alter the mitochondrial biogenesis in HEK293 cells. Nor did exogenous GJA1-20k affect membrane potential or baseline ATP production (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A-C</xref>). In addition to mitochondrial DNA copy number, neither biogenesis nor mitophagy protein markers were altered in either GJA1-20k transfected HEK293 cells or Gja1<sup>M213L/M213L</sup> mouse hearts (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D-G</xref>).</p></sec><sec id="s2-2"><title>Canonical mitochondrial dynamics are not involved</title><p>Mitochondrial dynamics are regulated by well-known mediators including DRP1 for fission (<xref ref-type="bibr" rid="bib17">Friedman and Nunnari, 2014</xref>), and MFN1 and MFN2 for fusion (<xref ref-type="bibr" rid="bib49">Schrepfer and Scorrano, 2016</xref>). DRP1 is potentiated by phosphorylation of its Serine 616 and 637 (<xref ref-type="bibr" rid="bib46">Sabouny and Shutt, 2020</xref>). We tested abundance of total DRP1 and phosphorylated DRP1 in GJA1-20k transfected HEK293 cells and found no significant difference in either the protein levels of total DRP1, DRP1-pS616, -pS637, or in the ratio (pS616/total) (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). The levels of MFN1 and MFN2, and mitochondrial marker protein TOM20, a marker of cellular mitochondrial content, were also unchanged (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>DRP1 is not involved in GJA1-20k-mediated mitochondrial fission.</title><p>(<bold>A</bold>) and (<bold>B</bold>) Western blot analysis for mitochondrial dynamics related proteins. Transfection was confirmed by GFP bands and the band size difference in GFP is due to the difference in molecular weight between GST and GJA1-20k (<bold>A</bold>). Tubulin was used as internal loading control. n = 5 independent experimental repeats. (<bold>C</bold>) Representative fixed cell images of mitochondria (visualized by Tom20) with DRP1 siRNA, K38A treatment, or Control. (<bold>D</bold>) The fold change in the average area of mitochondria in each treatment. n = 34 (GST, control siRNA), 32 (GJA1-20k, control siRNA), 36 (GST, DRP1 siRNA), 31 (GJA1-20k, DRP1 siRNA), 34 (GST, K38A), or 36 (GJa1-20k, K38A) cells from three independent experiments. Graphs were expressed as mean ± SD. p values were determined by two-tailed Mann-Whitney U-test or two-way ANOVA with Bonferroni’s post-hoc test. ***p &lt; 0.001; n.s., not significant. Scale bars, 5 μm (<bold>C</bold>). Exact p values and statistical data are provided in the source data.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>All data points of the protein expression and the mitochondrial size and the statistical data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69207-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Detailed analysis of DRP1 and DNM2 inhibition and GJA1-20k induced mitochondrial fission.</title><p>(<bold>A</bold>) and (<bold>G</bold>) Western blot analysis for DRP1 (<bold>A</bold>) or DNM2 (<bold>G</bold>) knock-down by siRNA. n = 3 independent experimental repeats. (<bold>B</bold>), (<bold>F</bold>), and (<bold>H</bold>) The representative fixed cell images of mitochondria (and DRP1 in <bold>B</bold>) with or without siDRP1 (<bold>B</bold>), DRP1-K38A (<bold>F</bold>), or siDNM2 (<bold>H</bold>) treatment. The magnified mitochondria images surrounded by the square in (<bold>B</bold>) and (<bold>F</bold>) are used in <xref ref-type="fig" rid="fig2">Figure 2</xref>. (<bold>C</bold>) % area of mitochondria associated with DRP1 with or without siDRP1 treatment. n = 34 (GST, siControl), 32 (GJA1-20k, siControl), 36 (GST, siDRP1), or 31 (GJA1-20k, siDRP1) cells from three independent experiments. (<bold>D</bold>) The representative fixed cell images of mitochondria with or without Mdivi-1 treatment. The right-most panels are magnified images surrounded by the square. (<bold>E</bold>) and (<bold>I</bold>) The fold change in the average area of mitochondria with or without Mdivi-1 (<bold>E</bold>) or siDNM2 (<bold>I</bold>) treatment. n = 32 (GST, DMSO), 33 (GJA1-20k, DMSO), or 29 (GST or GJA1-20k, Mdivi-1) cells; 40 (GST, siDNM2) or 33 (GJA1-20k, siDNM2) cells from three independent experiments. The graph of siControl and siDRP1 are used in <xref ref-type="fig" rid="fig2">Figure 2</xref>. Mitochondria were visualized by Tom20. Scale bars, 10 μm (<bold>B</bold>, <bold>D</bold>, and<bold> F</bold>) or 5 μm (<bold>B</bold> and <bold>D</bold> in magnified image, and <bold>H</bold>). Graphs were expressed as mean ± SD. p values were determined by two-way ANOVA with Bonferroni’s post-hoc test. ***p &lt; 0.001; n.s., not significant. Exact p values and statistical data are provided in the source data.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>All data points of % mitochondria area with DRP1 and mitochondrial size and the statistical data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69207-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-fig2-figsupp1-v1.tif"/></fig></fig-group><p>To further investigate whether GJA1-20k induced reduction in mitochondrial size is dependent on DRP1, we analyzed mitochondrial morphology after inhibiting DRP1 by performing siRNA-mediated <italic>DRP1</italic> knock-down (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A-C</xref>) or transfecting DRP1 dominant negative mutant (K38A), all with or without GJA1-20k transfection. With either method of DRP1 inhibition, the average area of individual mitochondria increased, consistent with inhibiting canonical fission (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>). In addition, K38A has more pronounced DRP1 inhibition which resulted in greater mitochondrial enlargement than siDRP1 (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>). However, GJA1-20k acts epistatically to DRP1 loss or interference and prevents DRP1-mediated mitochondrial enlargement (<xref ref-type="fig" rid="fig2">Figure 2C–F</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B,C</xref>), indicating GJA1-20k can act at or downstream of DRP1 activation. We also interfered mitochondrial dynamics by treating cells pharmacologically with mitochondrial division inhibitor 1 (Mdivi-1) and found same effects of GJA1-20k to rescue the dynamics (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D,E</xref>). In addition to DRP1, Dynamin-2 (DNM2) is also a GTPase which can potentially regulate mitochondrial fission (<xref ref-type="bibr" rid="bib34">Lee et al., 2016</xref>). To explore possible DNM2 involvement, we knocked-down DNM2 by siRNA and analyzed mitochondrial morphology. In contrast to siDRP1, siDNM2 alone did not affect mitochondrial morphology (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G-I</xref>), with or without GJA1-20k, suggesting no involvement of DNM2 in mitochondrial dynamics of HEK293 cell lines. It has been reported that DNM2 is not necessary to be responsible for mitochondrial fission in other cell lines as well (<xref ref-type="bibr" rid="bib15">Fonseca et al., 2019</xref>). The fact that DNM2 is not needed for GJA1-20k activity to occur, indicates it is not an essential co-factor in GJA1-20k-mediated mitochondrial fission.</p></sec><sec id="s2-3"><title>GJA1-20k interacts with actin to induce fission</title><p>The actin cytoskeleton and its dynamics have been implicated as fundamental mediators of mitochondrial fission (<xref ref-type="bibr" rid="bib33">Korobova et al., 2013</xref>; <xref ref-type="bibr" rid="bib24">Hatch et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Ji et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Moore et al., 2016</xref>). GJA1-20k has been previously identified to cluster with and stabilize the actin network both in vitro and in vivo (<xref ref-type="bibr" rid="bib3">Basheer et al., 2017</xref>). We imaged actin in GJA1-20k transfected HEK293 cells and noted that, in the presence of GJA1-20k, actin assembles around mitochondria, forming filamentous rings surrounding the outer membrane (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We used biochemical methods to confirm that GJA1-20k induces association of actin and mitochondria. Cytosolic and mitochondrial pools of proteins were separated and actin protein levels were measured in each fraction. As seen in <xref ref-type="fig" rid="fig3">Figure 3B and C</xref>, the large increase in mitochondrial associated actin occurs in the presence of GJA1-20k. Together these data provide both imaging and biochemical evidence that GJA1-20k recruits the actin cytoskeleton to the mitochondrial membrane.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>GJA1-20k stabilizes and recruits actin around mitochondria for fission.</title><p>(<bold>A</bold>) Representative live cell images of mitochondria with or without GJA1-20k. Actin was labeled by co-transfection with lifeAct-mCherry. The right-most panels indicate magnified images surrounded by square. (<bold>B</bold>) and (<bold>C</bold>) Western blot analysis in cytosol or mitochondrial fraction. MEK1/2 was used as cytosol marker and Tom20 and COX IV as mitochondrial markers (<bold>B</bold>). Quantification of actin in mitochondrial fraction normalized by Tom20 expression (<bold>C</bold>). n = 4 independent experimental repeats. (<bold>D</bold>) and (<bold>E</bold>) Cell-free actin polymerization (<bold>D</bold>) and depolymerization (<bold>E</bold>) assay. (<bold>F</bold>) Representative fixed cell images of mitochondria (visualized by Tom20) with or without LatA. (<bold>G</bold>) The fold change in the average area of mitochondria with or without LatA treatment. n = 32 (GST, DMSO), 33 (GST, LatA), 28 (GJA1-20k, DMSO), or 32 (GJA1-20k, LatA) cells from three independent experiments. Graphs were expressed as mean ± SD. p values were determined by two-tailed Mann-Whitney U-test or two-way ANOVA with Bonferroni’s post-hoc test. *p &lt; 0.05, ***p &lt; 0.001; n.s., not significant. Scale bars, 10 μm (<bold>F</bold>), 5 μm (<bold>A</bold> and magnified in <bold>F</bold>) and 2 μm (magnified in <bold>A</bold>). Exact p values and statistical data are provided in the source data.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>All data points of the actin assay and the mitochondrial size and the statistical data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69207-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-fig3-v1.tif"/></fig><p>The actin rings of <xref ref-type="fig" rid="fig3">Figure 3A</xref> are filamentous, indicating formation or stabilization of actin polymers. We asked how GJA1-20k alone, which localizes to the mitochondrial outer membrane (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>), can recruit and polymerize actin around mitochondria (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Using a reductionist cell-free assay of actin polymerization, we found that GJA1-20k does not directly promote actin polymerization (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), and the polymerization kinetics is even slightly slowed down in the presence of GJA1-20K. However, GJA1-20k causes a leftward shift in the polymerization-depolymerization equilibrium (<xref ref-type="bibr" rid="bib5">Blanchoin et al., 2014</xref>) by directly inhibiting actin depolymerization (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). The effect of substantial GJA1-20k, by inhibiting depolymerization, is to cause a net increase in polymerization. Because GJA1-20k enriches at outer mitochondrial membrane (<xref ref-type="bibr" rid="bib18">Fu et al., 2017</xref>; <xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>), the GJA1-20k-induced polymerization will occur at and around the mitochondrial membrane. Interestingly, GJA1-20k results in net actin polymerization even in the presence of Latrunculin A (LatA), a known potent inhibitor of actin polymerization (<xref ref-type="bibr" rid="bib20">Fujiwara et al., 2018</xref>; <xref ref-type="fig" rid="fig3">Figure 3E</xref>). In cells, it has been reported that LatA increases individual mitochondrial area, consistent with an inhibition of actin-dependent mitochondrial fission (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref>; <xref ref-type="bibr" rid="bib33">Korobova et al., 2013</xref>; <xref ref-type="bibr" rid="bib37">Moore et al., 2016</xref>; <xref ref-type="bibr" rid="bib35">Li et al., 2018</xref>). However, the presence of GJA1-20k counteracts the LatA effect, preserving acting polymerization and preventing an overall increase in mitochondrial size (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref>).</p><p>To investigate DRP1 involvement in the actin assemble by GJA1-20k, we observed the actin dynamics under siDRP1 treatment. Even under siDRP1, actin was assembled around mitochondria similarly to <xref ref-type="fig" rid="fig3">Figure 3A</xref> (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), suggesting that DRP1 is not necessary to create actin ring around mitochondria by GJA1-20k.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Time course of mitochondria dynamics and actin accumulation at the mitochondrial fission site under siDRP1.</title><p>(<bold>A</bold>) Representative live cell images of mitochondria with GJA1-20k under siDRP1. (<bold>B</bold>) Representative mitochondrial dynamics in GJA1-20k-transfected cells by time-lapse live cell imaging under siDRP1 treatment. The bottom images (with fire look-up table) indicate the product of GJA1-20k and actin signals. The white lines indicate mitochondrial outlines. Scale bars, 5 μm (<bold>A</bold>) and 2 μm (<bold>B</bold>). (<bold>C</bold>) The intensity of mitochondria and the product of GJA1-20k and actin from (<bold>B</bold>). The colored areas indicate fission sites along the lines shown in each respective insert. (<bold>D</bold>–<bold>F</bold>) The time course of the product of GJA1-20k and actin intensity (<bold>D</bold>), mitochondrial intensity (<bold>E</bold>), or combined relative intensity (<bold>F</bold>) at the fission site from the mitochondrion shown in (<bold>B</bold>). Curves are four parameters logistic (4PL) fits to the data. Time 0 corresponds to the peak product of actin and GJA1-20k intensity. The arrows indicate the time point at which fission is complete. (<bold>G</bold>) Measured time from peak product of actin and GJA1-20k intensity to fission in seconds (bars indicate median and 95 % confidence interval). n = 30 events. All data points are provided in the source data.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>All data points of the intensity and time-to-fission for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69207-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Time course of mitochondria dynamics and actin acumulation at the mitochondrial fission site under Mdivi-1 treatment.</title><p>(<bold>A</bold>) and (<bold>C</bold>) Representative mitochondrial dynamics in GJA1-20k-transfected cells by time-lapse live cell imaging under Mdivi-1 treatment. The bottom images (with fire look-up table) indicate the product of GJA1-20k and actin signals. The white lines indicate mitochondrial outlines. Scale bars, 2 μm. (<bold>B</bold>) and (<bold>D</bold>) The intensity of mitochondria and the product of GJA1-20k and actin from (<bold>A</bold>) and (<bold>C</bold>), respectively. The colored areas indicate fission sites along the lines shown in each respective insert. (<bold>E</bold>–<bold>G</bold>) The time course of the product of GJA1-20k and actin intensity (<bold>E</bold>), mitochondrial intensity (<bold>F</bold>), or combined relative intensity (<bold>G</bold>) at the fission site from the mitochondrion shown in (<bold>A</bold>). Curves are four parameters logistic (4PL) fits to the data. Time 0 corresponds to the peak product of actin and GJA1-20k intensity. The arrows indicate the time point at which fission is complete. (<bold>H</bold>) Measured time from peak product of actin and GJA1-20k intensity to fission in seconds (bars indicate median and 95% confidence interval). n = 29 events. All data points are provided in the source data.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>All data points of All data points of the intensity and time-to-fission for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69207-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Simultaneous use of fluorescently labelled actin, GJA1-20k, and mitochondria in live cells permit real time imaging of mitochondrial fission events at actin assembly sites. As seen in <xref ref-type="video" rid="video1">Video 1</xref> and <xref ref-type="fig" rid="fig4">Figure 4B</xref>, GJA1-20k recruits actin to mitochondria, which results in fission. In <xref ref-type="video" rid="video1">Video 1</xref>, the actin network can be seen to develop around mitochondria and, coinciding with GJA1-20k intensity, forms an increasingly tight band across a mitochondrion which, within one minute, results in mitochondrial fission. The imaging in the bottom row of <xref ref-type="fig" rid="fig4">Figure 4B</xref>, and in the right column of <xref ref-type="video" rid="video1">Video 1</xref> were obtained by multiplying GJA1-20k signal with actin signal, highlighting the locations at which GJA1-20k and actin are coincident. The respective line-scan profiles in <xref ref-type="fig" rid="fig4">Figure 4C</xref> indicate that mitochondrial fission occurs at points where the product of GJA1-20k and actin is the highest. Following accumulation of GJA1-20k and actin (red lines) at these points, a drop in mitochondrial signal (blue lines) is apparent when fission occurs. Fission (low point of blue lines) occurs approximately 45 seconds after co-accumulation of GJA1-20k and actin (high point of red lines, <xref ref-type="fig" rid="fig4">Figure 4C</xref>). Time to fission was computed from the time of peak GJA1-20k and actin intensity product, to the time of mitochondrial signal being reduced to background (<xref ref-type="fig" rid="fig4">Figure 4D–F</xref>). Statistically, this time to fission occurred at a median of 45 seconds, with a standard deviation of 11 seconds (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). Note, the real time imaging shown in <xref ref-type="video" rid="video1">Video 1</xref>, and <xref ref-type="fig" rid="fig4">Figure 4</xref> were performed under siDRP1. Therefore, the mitochondrial fission induced by cooperation between GJA1-20k and actin can be independent of canonical DRP1-mediated fission. To rule out inadvertent bias by siRNA, we used pharmacologic Mdivi-1 to inhibit DRP1 and, similar to the use of DRP1 siRNA, actin formed around mitochondria at GJA1-20k sites (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A-D</xref>) and fission occurred within a similar timescale (<xref ref-type="video" rid="video2">Videos 2</xref> and <xref ref-type="video" rid="video3">3</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E-H</xref>).</p><media id="video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-69207-video1.mp4"><label>Video 1.</label><caption><title>GJA1-20k assembles actin to mitochondrial fission sites and causes fission under siDRP1.</title><p>The mitochondrial fission in GJA1-20k-transfected HEK293 cells was monitored under siDRP1 treatment. GJA1-20k (tagged with GFP, green) and mitochondria (indicated by Mitotracker, blue) were simultaneously imaged (left panel), as were mitochondria and actin (indicated by LifeAct-mCherry, red) (middle panel). The spatial coincidence of GJA1-20k and actin were obtained by multiplying GJA1-20k signal with mitochondrial signal, as indicate with a polychromatic fire lookup table (right panel). Note GJA1-20k then actin surround the mitochondria, assembles at the neck of fission site, resulting in fission. The white arrowhead indicates the fission point. Images for each timepoint were obtained every 3 s. There are 17 images for a 51 second clip, played back at five frames per second (about 15 times as fast as real time). Still frames are indicated in <xref ref-type="fig" rid="fig4">Figure 4B</xref>.</p></caption></media><media id="video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-69207-video2.mp4"><label>Video 2.</label><caption><title>GJA1-20k assembles actin to mitochondrial fission sites and causes fission under Mdivi-1 (clip 1).</title><p>The mitochondrial fission in GJA1-20k-transfected HEK293 cells was monitored under Mdivi-1 treatment. GJA1-20k (tagged with GFP, green) and mitochondria (indicated by Mitotracker, blue) were simultaneously imaged (left panel), as were mitochondria and actin (indicated by LifeAct-mCherry, red) (middle panel). The spatial coincidence of GJA1-20k and actin were obtained by multiplying GJA1-20k signal with mitochondrial signal, as indicate with a polychromatic fire lookup table (right panel). Note GJA1-20k then actin surround the mitochondria, assembles at the neck of fission site, resulting in fission. The white arrowhead indicates the fission point. Images for each timepoint were obtained every 3 ss. There are 26 images for a 78 second clip, played back at five frames per second (about 15 times as fast as real time). Still frames are indicated in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>.</p></caption></media><media id="video3" mime-subtype="mp4" mimetype="video" xlink:href="elife-69207-video3.mp4"><label>Video 3.</label><caption><title>GJA1-20k assembles actin to mitochondrial fission sites and causes fission under Mdivi-1 (clip 2).</title><p>The mitochondrial fission in GJA1-20k-transfected HEK293 cells was monitored under Mdivi-1 treatment. GJA1-20k (tagged with GFP, green) and mitochondria (indicated by Mitotracker, blue) were simultaneously imaged (left panel), as were mitochondria and actin (indicated by LifeAct-mCherry, red) (middle panel). The spatial coincidence of GJA1-20k and actin were obtained by multiplying GJA1-20k signal with mitochondrial signal, as indicate with a polychromatic fire lookup table (right panel). Note GJA1-20k then actin surround the mitochondria, assembles at the neck of fission site, resulting in fission. The white arrowhead indicates the fission point. Images for each timepoint were obtained every 3 s. There are 81 images for a 243 second clip, played back at five frames per second (about 15 times as fast as real time). Still frames are indicated in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>.</p></caption></media></sec><sec id="s2-4"><title>GJA1-20k induces protective effects against oxidative stress</title><p>It has been found that AAV9-mediated GJA1-20k overexpression in mouse heart depresses mitochondrial respiration, which has the beneficial effect of limiting myocardial infarction after ischemic-reperfusion (I/R) injury (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>). We measured oxygen consumption rate (OCR) using a Seahorse mitochondrial stress test in GJA1-20k transfected HEK293 cells and found a decrease in maximal respiration (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>), consistent with previous results (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>). Similarly, maximal respiration is increased in neonatal CMs derived from GJA1-20k deficient <italic>Gja1<sup>M213L/M213L</sup></italic> mice and maximal respiration for heterozygous <italic>Gja1<sup>M213L/WT</sup></italic> mice is between that of WT and <italic>Gja1<sup>M213L/M213L</sup></italic> (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A,B</xref>). In addition, observing other OCR parameters, we found a decrease in ATP-linked respiration and reserve capacity in <italic>Gja1<sup>M213L/WT</sup></italic> cardiomyocytes, and an increase in proton leak and non-mitochondrial respiration in <italic>Gja1<sup>M213L/M213L</sup></italic> suggesting that there can be compensatory long-term effects of the <italic>Gja1</italic> mutation (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Mitochondrial metabolic function is preserved by GJA1-20k.</title><p>(<bold>A</bold>–<bold>D</bold>) Real-time change in OCR by Seahorse assay and the maximum respiration in HEK293 cells (<bold>A and B</bold>) and mouse neonatal CM (<bold>C and D</bold>). 7 (GST) or 8 (GJA1-20k) replicates from HEK293 cells; n = 24 (WT and Gja1<sup>M213L/WT</sup> from four hearts) or 16 (Gja1<sup>M213L/M213L</sup> from three hearts) replicates. (<bold>E</bold>) Representative images of TTC stained hearts from WT and Gja1<sup>M213L/WT</sup> mice post-I/R. (<bold>F</bold>) Quantification of infarct size after I/R. n = 4. (<bold>G</bold>) Representative images of DHE staining post-I/R from WT or Gja1<sup>M213L/WT</sup> heart. (<bold>H</bold>) Relative intensity of DHE. n = 30 images from three hearts in each genotypes. (<bold>I</bold>) The representative electron microscope images from adult mouse hearts under basal or post-I/R (WT or Gja1<sup>M213L/WT</sup>). (<bold>J</bold>) The fold change in the average area of individual mitochondria. n = 240 (WT, Basal), 225 (Gja1<sup>M213L/WT</sup>, Basal), 229 (WT, post-I/R), or 224 (Gja1<sup>M213L/WT</sup>, post-I/R) mitochondria from three hearts. (<bold>K</bold>) % area of mitochondria matrix post-I/R. n = 229 (WT, post-I/R), or 224 (Gja1<sup>M213L/WT</sup>, post-I/R) mitochondria from three hearts. (<bold>L</bold>) The distribution of the data set in (<bold>K</bold>). Graphs were expressed as mean ± SD (HEK293) or SEM (mouse). p values were determined by two-tailed Mann-Whitney U-test, Kruskal-Wallis test with Dunn’s post-hoc test, or two-way ANOVA with Bonferroni’s post-hoc test. *p &lt; 0.05, ***p &lt; 0.001; †††p &lt; 0.001 compared to WT post-I/R; n.s., not significant. Scale bars, 5 mm (<bold>E</bold>); 50 μm (<bold>G</bold>); 2 μm (<bold>I</bold>). Exact p values and statistical data are provided in the source data.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>All data points of the seahorse assay, infarct size, DHE intensity, and mitochondrial analysis and the statistical data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69207-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>The details of difference between WT and heterozygous Gja1<sup>M213L/WT</sup> and ROS generation induced by H<sub>2</sub>O<sub>2</sub> stimulation.</title><p>(<bold>A</bold>) Representative live cell images of mitochondria in mouse neonatal CMs from heterozygous Gja1<sup>M213L/WT</sup> mice. (<bold>B</bold>) The fold change in the average area of individual mitochondria. n = 46 (WT) or 48 (Gja1<sup>M213L/WT</sup>) images from four hearts. WT data is used in <xref ref-type="fig" rid="fig1">Figure 1</xref>. (<bold>C</bold>) Quantification of respiration, Proton-leak, Maximum respiration, ATP-production, Reserve capacity, and Non-mitochondrial respiration among genotypes (WT, white; Gja1<sup>M213L/WT</sup>, blue; Gja1<sup>M213L/M231L</sup>, red). (<bold>D</bold>) and (<bold>H</bold>) Representative live cell images of ROS generation in HEK293 cells with GST or GJA1-20k (<bold>D</bold>); or GST or DRP1 (<bold>H</bold>). (<bold>E</bold>) and (<bold>I</bold>) Relative intensity of mitoSOX (<bold>E</bold>) or cellROX (<bold>I</bold>). n = 39 (GST, PBS), 41 (GST, H<sub>2</sub>O<sub>2</sub>), or 37 (GJA1-20k, PBS or H<sub>2</sub>O<sub>2</sub>) cells; or 40 (GST, PBS), 43 (GST, H<sub>2</sub>O<sub>2</sub>), 48 (DRP1, PBS), or 47 (DRP1, H<sub>2</sub>O<sub>2</sub>) cells from three independent experiments. (<bold>F</bold>) Representative live cell images of mitochondria in HEK293 cells with DRP1 transfection. The bottom panels are magnified images surrounded by square. (<bold>G</bold>) T the fold change in the average area of mitochondria. n = 47 cells from three independent experiments. GST data is used in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Graphs were expressed as mean ± SD (HEK293) or± SEM (mouse). p values were determined by two-tailed Mann-Whitney U-test or Kruskal-Wallis test with Dunn’s post-hoc test, or two-way ANOVA with Bonferroni’s post-hoc test. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001; †††p &lt; 0.001 compared to GST H<sub>2</sub>O<sub>2</sub>. Scale bars, 10 μm and 5 μm in magnified images. Exact p values and statistical data are provided in the source data.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>All data points of the mitochondrial size, the detailed seahorse data, and intensity of ROS measurement and the statistical data for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69207-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-fig5-figsupp1-v1.tif"/></fig></fig-group><p>To explore whether GJA1-20k is necessary to protect against oxidative injury in heart muscle, we subjected Langendorff-perfused adult hearts from heterozygous <italic>Gja1<sup>M213L/WT</sup></italic> mice to ischemia-reperfusion (I/R) injury. Since homozygous <italic>Gja1<sup>M213L/M213L</sup></italic> mice die in 2–4 weeks after birth, we used heterozygous <italic>Gja1<sup>M213L/WT</sup></italic> mice to be able to work with adult hearts. At baseline, adult <italic>Gja1<sup>M213L/WT</sup></italic> mice with an approximately 50% reduction of GJA1-20k expression, have no change in overall phenotype, or cardiac chamber dimensions or cardiac functional characteristics compared to WT mice, as measured by echocardiography (<xref ref-type="bibr" rid="bib63">Xiao et al., 2020</xref>). However, remarkably, reduced GJA1-20k expression results in an almost complete cardiac infarction after I/R injury (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>). Moreover, ROS production after I/R injury was increased in <italic>Gja1<sup>M213L/WT</sup></italic> mice compared to WT post-I/R (<xref ref-type="fig" rid="fig5">Figure 5G and H</xref>). There was no significant difference in mitochondria size at the basal condition between WT and <italic>Gja1<sup>M213L/WT</sup></italic> mice adult CMs as with neonatal CMs (<xref ref-type="fig" rid="fig5">Figure 5I and J</xref>), whereas the mitochondria size was significantly increased after I/R injury and the heterozygous <italic>Gja1<sup>M213L/WT</sup></italic> mice had larger mitochondria compared to WT mice post-I/R (<xref ref-type="fig" rid="fig5">Figure 5I and J</xref>). Interestingly, the area of mitochondrial matrix was also increased, suggesting loss of cristae in <italic>Gja1<sup>M213L/WT</sup></italic> mice heart (<xref ref-type="fig" rid="fig5">Figure 5K and L</xref>). These data indicate that even partial deletion of GJA1-20k results in a profoundly impaired response to ischemic stress.</p><p>Given that GJA1-20k is a stress-responsive protein which can mediate ischemic preconditioning (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>) and to explore the protective effects of GJA1-20k against oxidative stress, we measured mitochondrial generation of reactive oxygen species (ROS) in HEK293 cells under oxidative stress induced by exogenous H<sub>2</sub>O<sub>2</sub> treatment. In unstressed cells, the presence of GJA1-20k does not affect mitochondrial ROS generation (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D,E</xref>) whereas in the presence of exogenous H<sub>2</sub>O<sub>2</sub>, GJA1-20k prevents an increase in mitochondrial ROS (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D,E</xref>). Thus, GJA1-20k, which depresses mitochondrial respiration in unstressed cells, does not affect homeostatic ROS generation, yet has the beneficial effect of decreasing toxic ROS generation during stress (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D,E</xref>). To clarify whether the protective effects come from GJA1-20k expression or mitochondrial size, we measured ROS from HEK293 cells with DRP1 overexpression instead of GJA1-20k overexpression. DRP1 overexpression decreased in mitochondrial size similar to GJA1-20k (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F,G</xref>). However, ROS generation induced by H<sub>2</sub>O<sub>2</sub> was significantly increased and higher than GST control under H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1H,I</xref>). Taken together, GJA1-20k itself is necessary for the protective mitochondrial fission.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In conclusion, we find that the stress-responsive protein GJA1-20k organizes actin around mitochondria, promoting an actin-dependent mitochondrial fission process that also protects against oxidative and ischemic stress (cartoon in <xref ref-type="fig" rid="fig6">Figure 6</xref>). This protective fission pathway is distinct from canonical DRP1-mediated fission. In heart muscle, GJA1-20k appears to be critical to limit ischemic damage. Adult mice heterozygous for the internal GJA1-20k start have normal baseline cardiac phenotypes, yet suffer almost complete myocardial infarctions once subjected to I/R injury (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Schematic summary.</title><p>GJA1-20k, internally translated from Gja1 mRNA, localizes mitochondria membrane, stabilizes actin cytoskeleton, and recruits actin around mitochondria to both induce mitochondrial fission and achieve oxidative stress resistance.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-fig6-v1.tif"/></fig><p>Mitochondrial fusion and fission dynamics are understood to involve several key molecules. MFN1 and MFN2 have important roles in fusion (<xref ref-type="bibr" rid="bib49">Schrepfer and Scorrano, 2016</xref>), while DRP1 mediates canonical fission (<xref ref-type="bibr" rid="bib17">Friedman and Nunnari, 2014</xref>). A dynamic equilibrium between fusion and fission is important during development as well as in response to a changing cellular environment. Alteration of the equilibrium point between fusion and fission occurs with disease (<xref ref-type="bibr" rid="bib10">Chan, 2006</xref>). Additionally, in mouse heart, hypertrophy or dilated cardiomyopathy result from either MFN1 or MFN2 deletion (which causes mitochondrial fragmentation) or DRP1 deletion (which causes hyperfused mitochondria)(<xref ref-type="bibr" rid="bib53">Song et al., 2015</xref>). The implication is that either a leftward or rightward shift in the fusion-fission equilibrium can negatively affect cardiac function. However, it is becoming increasingly clear that mitochondrial size alone, the easiest readout of mitochondrial dynamics, is insufficient to interpret whether destructive or pro-survival pathways are dominant. The presence of GJA1-20k, which increases with ischemic and oxidative stress (<xref ref-type="bibr" rid="bib59">Ul-Hussain et al., 2014</xref>; <xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>), is clearly beneficial in the setting of I/R injury (<xref ref-type="fig" rid="fig5">Figure 5G and H</xref>). Yet the presence of GJA1-20k, while inducing mitochondrial fission and smaller mitochondria (<xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig3">3</xref> and <xref ref-type="fig" rid="fig4">4</xref>), does not either reduce MFN1 or MFN2, activate DRP1, change membrane potential, ATP production, mitochondrial biogenesis, or mitophagy (<xref ref-type="fig" rid="fig2">Figure 2</xref>; <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). The ability of GJA1-20k to recruit actin to induce fission independently of DRP1 is novel. GJA1-20k use of actin to cause fission occurs rapidly, within 45 s of peak GJA1-20k and actin coincidence at mitochondrial membrane (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). We have also investigated the involvement of DNM2 as another GTPase for the mitochondrial fission, but DNM2 knock-down failed to induce sufficient mitochondrial fusion or alter the effects of GJA1-20k (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G-I</xref>). Therefore, it does not appear that DNM2 is essential for GJA1-20k activity on mitochondrial fission. In addition to actin, the endoplasmic reticulum (ER) membrane can be involved in mitochondrial scission (<xref ref-type="bibr" rid="bib16">Friedman et al., 2011</xref>; <xref ref-type="bibr" rid="bib57">Tandler et al., 2018</xref>). Future studies should be considered whether GJA1-20k induced actin cytoskeleton arrangements involves ER membrane as well.</p><p>Given the rapidity (less than one minute) of GJA1-20k induced fission, it is of interest how fission activity can be limited in stable cells, especially terminally differentiated cells such as adult cardiomyocytes. We have not yet evaluated whether secondary regulators or post-translational modification of either primary actin or GJA1-20k affects GJA1-20k mediated mitochondrial dynamics. One simple form of regulation is in the abundance of GJA1-20k. The paucity of GJA1-20k at baseline, and its large and rapid increase during the onset of ischemic stress (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>), support the role of GJA1-20k as a stress responsive process which affords acute protection during ischemic injury.</p><p>While smaller mitochondrial size has been traditionally associated with mitochondrial fragmentation and poor cellular health (<xref ref-type="bibr" rid="bib60">Wai and Langer, 2016</xref>), it is now understood that there is a more complex relationship between mitochondrial size and mitochondrial function (<xref ref-type="bibr" rid="bib54">Sprenger and Langer, 2019</xref>). Smaller mitochondria can signal not only disease but also tissue protection and adaptation. DRP1-induced fission and smaller mitochondria are associated with excess ROS production, apoptosis, and organ injury (<xref ref-type="bibr" rid="bib29">Hu et al., 2017</xref>; <xref ref-type="bibr" rid="bib61">Wang et al., 2017</xref>), which is also seen in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F-I</xref>, whereas DRP1-independent mitochondrial fission has been observed in cells undergoing protective mitophagy (<xref ref-type="bibr" rid="bib55">Stavru et al., 2013</xref>; <xref ref-type="bibr" rid="bib64">Yamashita et al., 2016</xref>; <xref ref-type="bibr" rid="bib11">Coronado et al., 2018</xref>). It appears that GJA1-20k-mediated fission is highly beneficial, and part of a pro-survival cellular response to stress. Our results suggest that mitochondrial morphology (i.e. the overall balance of fusion and fission) in stressed cells should be considered in the context of the presence of specific proteins. For instance, pathological fission in the presence of activation of DRP1 might indicate mitophagy (<xref ref-type="bibr" rid="bib30">Ikeda et al., 2015</xref>; <xref ref-type="bibr" rid="bib9">Burman et al., 2017</xref>; <xref ref-type="bibr" rid="bib61">Wang et al., 2017</xref>), whereas an increase in GJA1-20k implies a stress-induced reduction of ROS generation and beneficial depression of metabolism. Both DRP1 activation and GJA1-20k generation result in mitochondrial fission, but have different implications for cellular health.</p><p>Since its first report 35 years ago, investigators have both tried to understand the mechanisms of preconditioning as well as use putative mediators of precondition to benefit organs undergoing anticipated ischemia. These efforts have included dozens of preclinical and proof-of-concept studies, yet without success (<xref ref-type="bibr" rid="bib28">Heusch and Gersh, 2020</xref>). Mediators such as cyclophilin D (<xref ref-type="bibr" rid="bib12">Cung et al., 2015</xref>), cardiolipin (<xref ref-type="bibr" rid="bib23">Gibson et al., 2016</xref>), mitochondrial permeability transition pore (MPTP)(<xref ref-type="bibr" rid="bib48">Schaller et al., 2010</xref>; <xref ref-type="bibr" rid="bib2">Atar et al., 2015</xref>), Cx43 (<xref ref-type="bibr" rid="bib50">Schulz et al., 2015</xref>), ATP-dependent K<sup>+</sup> channels (<xref ref-type="bibr" rid="bib25">Heinzel et al., 2005</xref>; <xref ref-type="bibr" rid="bib22">Garlid et al., 2009</xref>), STAT3 (<xref ref-type="bibr" rid="bib26">Heusch et al., 2011</xref>), GSK3-beta (<xref ref-type="bibr" rid="bib32">Juhaszova et al., 2004</xref>), and opioid receptors <xref ref-type="bibr" rid="bib14">Dragasis et al., 2013</xref> have been implicated in preconditioning protection (<xref ref-type="bibr" rid="bib27">Heusch and Gersh, 2017</xref>), but replicating their involvement in clinical studies has, to present, failed to be successful. More recently, the phenomenon of remote preconditioning has been explored as a therapeutic solution, but clinical application of this approach has also yet to be successful (<xref ref-type="bibr" rid="bib28">Heusch and Gersh, 2020</xref>). It is possible that the reason a central mediator of preconditioning has not been determined is that it has not been available for study. GJA1-20k was only first reported to occur endogenously in 2013 (<xref ref-type="bibr" rid="bib52">Smyth and Shaw, 2013</xref>) and its association with mitochondria and potential beneficial effects for survival of I/R was reported in the last 3 years (<xref ref-type="bibr" rid="bib18">Fu et al., 2017</xref>; <xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>; <xref ref-type="bibr" rid="bib62">Wang et al., 2019</xref>; <xref ref-type="bibr" rid="bib19">Fu et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Ren et al., 2020</xref>). As a smaller isoform of Cx43 that contains the epitope of most anti-Cx43 antibodies, and is localized to mitochondria (<xref ref-type="bibr" rid="bib18">Fu et al., 2017</xref>), GJA1-20k could be central to the studies that implicated Cx43 as a mediator of preconditioning. As a stress-responsive protein (<xref ref-type="bibr" rid="bib59">Ul-Hussain et al., 2014</xref>; <xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>), endogenous GJA1-20k is induced by short bouts of ischemia prior to a longer ischemic period (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>). Because GJA1-20k-induced fission is associated with less ROS production with oxidative stress (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>, E), the endogenous generation of GJA1-20k and subsequent decreased ROS production could explain a major benefit of pre-conditioning. Of note, genetic GJA1-20k reduction increases infarct size and ROS production post-I/R injury (<xref ref-type="fig" rid="fig5">Figure 5E–H</xref>). In addition, the population of damaged mitochondria is significantly increased in heterozygous <italic>Gja1<sup>M213L/WT</sup></italic> mouse heart post-I/R (<xref ref-type="fig" rid="fig5">Figure 5I–L</xref>). Therefore, GJA1-20k induced decreases in ROS production could limit the amount of I/R injury induced by myocardial infarction.</p><p>Major cardiovascular procedures are associated with low flow and ischemia related damage to end-organs such as the heart, kidneys, and brain. A priori gene therapy mediated delivery of GJA1-20k to these organs could be beneficial. For instance, percutaneous coronary interventions are associated with both cardiac and renal damage (<xref ref-type="bibr" rid="bib8">Brown et al., 2008</xref>; <xref ref-type="bibr" rid="bib58">Tricoci et al., 2018</xref>) and could benefit from GJA1-20k-induced protection. Similarly, coronary bypass surgery with cardiopulmonary bypass is associated with low flow damage to the brain and kidneys (<xref ref-type="bibr" rid="bib44">Roach et al., 1996</xref>; <xref ref-type="bibr" rid="bib36">McKhann et al., 2006</xref>; <xref ref-type="bibr" rid="bib41">O’Neal and Shaw, 2016</xref>), and abdominal aorta surgery is associated with renal damage, all of which may benefit from viral-mediated GJA1-20k pretreatment.</p><p>It is also possible, as suggested by unpublished preliminary studies by our group, that GJA1-20k peptide administration intravenously can gain access to the intracellular environments of the heart and other organs. In this scenario, GJA1-20k administration could occur minutes to hours ahead of an ischemic insult rather than the presumably days to weeks which would be needed for viral-mediated introduction. Future studies will focus on acute intravenous administration of GJA1-20k peptide in subjects about to undergo anticipated ischemia.</p><p>The phenomenon of stunned myocardium is common in patients with I/R injury such as experiencing an occluded coronary artery that is revascularized, but the mechanism of stunning is not well elucidated. It is possible that stunned myocardium has elevations of GJA1-20k after the ischemic injury. Of note, stunned myocardium is metabolically quiescent and also exhibits smaller mitochondria (<xref ref-type="bibr" rid="bib6">Borgers et al., 1993</xref>; <xref ref-type="bibr" rid="bib7">Borgers, 2002</xref>), further supporting the possibility that GJA1-20k is involved in the stunned response to ischemia as a mechanism of preventing myocardial death. Endogenous induction of GJA1-20k may also explain other instances when smaller mitochondrial size correlates with a beneficial effect (<xref ref-type="bibr" rid="bib11">Coronado et al., 2018</xref>). Recent studies have identified that exogenous GJA1-20k can protect neurons subjected to traumatic brain injury (<xref ref-type="bibr" rid="bib43">Ren et al., 2020</xref>), hearts from ischemia (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>) and angiotensin induced hypertrophy (<xref ref-type="bibr" rid="bib19">Fu et al., 2020</xref>). Furthermore, by mimicking the protection afforded by ischemic preconditioning, exogenous GJA1-20k is a promising therapeutic to protect hearts, brains and other organs against expected ischemic damage.</p><p>We have found that neither exogenous GJA1-20k overexpression in mouse hearts nor GJA1-20k<sup>M213L/WT</sup> adult mice have altered unstressed cardiac function (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>; <xref ref-type="bibr" rid="bib63">Xiao et al., 2020</xref>). However acute administration of GJA1-20k or using GJA1-20k in the context of stressed myocardium could conceivably result in diminished cardiac function. As GJA1-20k is stress responsive, an increase in GJA1-20k may be a mediator of post-ischemic protection (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>), and even responsible for the phenomenon of myocardial stunning which happens to be associated with small mitochondria (<xref ref-type="bibr" rid="bib6">Borgers et al., 1993</xref>; <xref ref-type="bibr" rid="bib7">Borgers, 2002</xref>). On the other hand, GJA1-20k induced functional hibernation of stressed myocardium, while increasing survival, could conceivably result in diminished cardiac function. If indeed GJA1-20k induces an acute cardiac depressant response, appropriate steps would be needed to compensate for lower cardiac output during the myocardial protection period.</p><p>In summary, we identify that upregulation of the stress-responsive internally translated peptide, GJA1-20k, may be a critical mediator of ischemic-preconditioning protection. GJA1-20k induces fission by recruiting actin to mitochondria, inducing a fission that decreases ROS generation and protects organs such as the heart. Use of exogenous GJA1-20k as a therapeutic can potentially realize the long sought yet still elusive clinical need of preventing organs from undergoing damage during anticipated ischemia.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals</title><p>All mice were maintained under sterile barrier conditions. For the exogenous gene delivery, we used C57BL/6 male mice under same conditions at the age of 8 weeks to start the study procedure according to previous study (<xref ref-type="bibr" rid="bib3">Basheer et al., 2017</xref>; <xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>). We injected 100 μl of 3 × 10<sup>11</sup> vector genomes per mL of Adeno-associated virus type 9 (AAV9) vectors containing GFP-tagged glutathione S-transferase (GST-GFP) or GJA1-20k (GJA1-20k-GFP) driven by the cytomegalovirus (CMV) promoter through retro-orbital injection. Eight weeks post-injection, the heart dissection was performed under anesthesia by isoflurane. Heparin (100 IU, i.p.) was injected 20–30 min before dissection. We perfused the heart with cold HEPES buffer to wash out the blood and immediately freeze and proceed DNA extraction. The details of <italic>Gja1</italic><sup>M213L/M213L</sup> mouse generation has been described previously (<xref ref-type="bibr" rid="bib63">Xiao et al., 2020</xref>). We isolated neonatal cardiomyocyte (postnataTl 2–3 days) from <italic>Gja1</italic><sup>M213L/M213L</sup> and Wildtype (WT) mice using Pierce Primary Cardiomyocyte Isolation Kit (Thermo Fisher Scientific, Walthman, MA) following manufacturer protocol. The neonatal cardiomyocyte was seeded into gelatin/fibronectin coated 35 mm glass-bottomed dish and subjected to imaging as described below. Adenovirus encoding GJA1-20k-V5 (GFP-V5 as a control; four plaque-forming unit/cell) was transduced as previously described <xref ref-type="bibr" rid="bib3">Basheer et al., 2017</xref> followed by live cell imaging. The average area of individual mitochondria in GFP-V5 control myocyte was unchanged compared to WT non-transduced cardiomyocytes (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D, E</xref>). We also dissected the heart tissue at the age of 2 weeks from <italic>Gja1</italic><sup>M213L/M213L</sup> and WT mice under anesthesia described above for the following experiments. All animal care and study protocols were approved by University of Utah Institutional Animal Care and Use Committee.</p></sec><sec id="s4-2"><title>Electron microscope imaging</title><p>The mouse hearts were prepared as described previously (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>). Briefly, the adult mouse hearts were fixed by perfusing with 2% glutaraldehyde and 2% paraformaldehyde in PBS for 10 min followed by post-fixed with 1% osmium tetroxide and incubated in 3% uranyl acetate. The small hearts from young mouse (2 weeks old) dissected into 1 mm pieces were immediately fixed with 2.5% glutaraledehyde, 1% paraformaldehyde, 0.1 M Cacodylate buffer, pH 7.4, 6 mM CaCl<sub>2</sub>, 4.8 % Sucrose, at 4°C. Following overnight fixation, the specimens were rinsed two times in buffer and were postfixed in 2% Osmium tetroxide for 1 hr at room temperature. The specimens were rinsed in dH<sub>2</sub>O and pre-stained with uranyl acetate for 1 hr ate room temperature. Then the samples were dehydrated in graded ethanol series and three times in pure acetone then infiltrated and embedded in epoxy resin, Embed 812 (cat # 14121, Electron Microscopy Sciences, Hatfield, PA). The blocks were cut at 70 nm thickness using an ultramicrotome (Leica, Wetzlar, Germany) and poststained with uranyl acetate for 10 min, and lead citrate for 5 min. Sections were examined at an accelerating voltage of 120 kV in a JEM-1400 plus or JEM1200-EX (JEOL, Tokyo, Japan) transmission electron microscope with CCD Gatan camera. The number and the total area of mitochondria in each image were measured using imageJ and the average area was calculated by dividing the total area by the number. Electron microscope imaging was performed by the core facility at Electron Microscopy Laboratory at University of Utah and at the Electron Imaging Center of The California NanoSystems Institute at University of California, Los Angeles.</p></sec><sec id="s4-3"><title>Cell culture, plasmid and siRNA transfection, DRP1 inhibition, and Latrunculin a treatment</title><p>HEK293 cells were purchased from Thermo Fisher Scientific (R70007) and cultured with DMEM containing 10 % fetal bovine serum (FBS), non-essential amino acids, sodium pyruvate (Thermo Fisher Scientific), and Mycozap-CL (Lonza) in 37°C, 5% CO<sub>2</sub> incubator. The cell line was tested negative for mycoplasma contamination. For imaging analysis, we coated 35 mm glass-bottomed dish with 0.1% gelatin (Sigma-Aldrich, St. Louis, MO) and human fibronectin (20 μg/ml, Corning) incubating 37°C for 2 hr or 4 °C overnight before cell seeding. We seeded the cells (2.0 × 10<sup>5</sup> cells/dish) into the coated dishes and harvested in the incubator. Next day, we transfected GST- or GJA1-20k-GFP, mCherry-DRP1, or Drp1K38A (0.5 μg/dish) with or without LifeAct-mCherry (1.0 μg/dish) plasmids as described previously (<xref ref-type="bibr" rid="bib18">Fu et al., 2017</xref>), using FuGene HD (Promega, Madison, WI) following manufacturer protocol. The constructs are driven by CMV promoter and internal methionine in GJA-20k was mutated to leucine to express a single isoform as described previously (<xref ref-type="bibr" rid="bib52">Smyth and Shaw, 2013</xref>). After overnight transfection, the cells were subjected to imaging or protein extraction. To obtain enough proteins from 100 mm culture dish, we multiplied the plasmid concentration based on bottom surface area of 35 mm dish (approximately 0.05 μg/cm<sup>2</sup>). To knock-down Gja1, DRP1, or DNM2, we used Gja1 siRNA (Thermo Fisher Scientific, ID HSS178257), DRP1 siRNA (Thermo Fisher Scientific, ID 19561), DNM2 siRNA (Thermo Fisher Scientific, ID s4212), and Stealth RNAiTM (Thermo Fisher Scientific) as negative control. We transfected 25 pmol of siRNA by LipofectamineTM RNAiMAX (Thermo Fisher Scientific) following manufacturer protocol. After overnight incubation, GST- or GJA1-20k-GFP plasmid was transfected as described above and the samples were subjected to subsequent experiments. To confirm the knock-down, we used six-well culture plate and proceed knock-down exactly same way and same time followed by protein extraction described below. For pharmacological DRP1 inhibition, a mitochondrial division inhibitor 1 (Mdivi-1, 50 μM) or the equal amount of Dimethyl sulfoxide (DMSO) diluted in culture medium was added to the cells at the same time as the plasmid transfection. After overnight incubation, the samples were subjected to imaging. To disrupt the actin polymerization, the cells after the transfection were incubated for 1 hour with Latrunculin A (LatA; 100 nM) or the equal amount of DMSO diluted in culture medium. After the incubation, the samples were subjected to imaging.</p></sec><sec id="s4-4"><title>Confocal live and fixed cell imaging</title><p>We followed the protocol described previously (<xref ref-type="bibr" rid="bib18">Fu et al., 2017</xref>). The imaging was performed using a Nikon Eclipse Ti imaging system with a × 100/1.49 Apo TIRF objective, a spinning disk confocal unit (Yokogawa, Tokyo, Japan) with 486, 561, and 647 nm diode-pumped solid state lasers, and an ORCA-Flash 4.0 Hamamatsu camera, controlled by NIS Elements software. For live cell imaging, the cells were imaged in culture medium using DMEM without Phenol Red (Thermo Fisher Scientific) for snapshot or time-lapse imaging. The imaging chamber was maintained 37°C and 5% CO<sub>2</sub>. Mitochondria were labeled by incubating 37 °C for 20 minutes with Mitotracker (200 nM, Thermo Fisher Scientific) before imaging. To measure the mitochondrial membrane potential, we used TMRE (200 nM, Cayman Chemical Company, Ann Arbor, MI) incubating for 20 min at 37°C before imaging. For fixed cell imaging, the cells were fixed by 4% paraformaldehyde for 30 min at room temperature. After fixation, the samples were permeabilized in 0.1% TritonX-100 in PBS for 10 min, washed with PBS 2 × 5 min, and blocked in 5% normal goat serum (NGS) in PBS for 2 hr at room temperature. The following primary antibodies were diluted in 1% NGS in PBS and incubated in dark moisture chamber at 4°C overnight; anti-GFP (1:2000, Abcam), anti-TOM20 (1:1000, Abcam), ant-DRP1 (1:250, Abcam). Next day, the samples were washed with PBS 3 × 10 min and incubated with host-matched immunoglobin cross-adsorbed secondary antibodies conjugated with Alexa Fluor 488, 555, 647 (1:500, Invitorgen, Carlsbad, CA) in 1 % NGS in PBS for 1 hr at room temperature. After washing with PBS 3 × 10 min, the samples were mounted with ProLong Gold antifade regent with DAPI (Thermo Fisher Scientific). For image analysis, we used ImageJ with the mito-morphology plugin (<xref ref-type="bibr" rid="bib13">Dagda, 2009</xref>) for mitochondrial morphology analysis.</p></sec><sec id="s4-5"><title>Western blot analysis</title><p>We performed Western blot as previously described (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>). We harvested the cells in 100 mm culture dish or six-well plate for knock-down experiment transfected plasmid as described above. The cells were lysed by RIPA buffer (containing 50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% TritonX-100, 1% Sodium Deoxycholate, 1 mM NaF, 0.2 mM Na<sub>3</sub>VO<sub>4</sub>, and Halt Proteinase and Phosphatase Inhibitor Cocktail (Thermo Fisher Scientific)) to extract total protein. The lysate was sonicated on ice, rotated for 1 hr at 4°C, and centrifuged 16,000× g for 20 min at 4°C. The supernatant was collected as the protein sample. To extract mitochondrial fraction, we used Mitochondria Isolation Kit for Cultured Cells (Thermo Fisher Scientific) following manufacturer protocol. The protein concentration was measured using DC Protein Assay (Bio-Rad, Hercules, CA). The protein samples with sample buffer (NuPAGE LDS sample buffer (NP0007) containing 100 mM DTT) were separated using NuPAGE Bis-Tris gels (4%–12%) with 3-(N-morpholino)propanesulfonic acid (MOPS) or 2-(N-morpholino)ethanesulfonic acid (MES) running buffer (Thermo Fisher Scientific) followed by transferring to polyvinylidene difluoride (PVDF) membrane (Pall Corporation, Port Washington, NY). After the transferring, the membrane was fixed by soaking in methanol, air drying, and rewetting in methanol followed by blocking with 5% non-fat milk or bovine serum albumin (for phosphorylated protein detection) in Tris-NaCl-Tween (TNT) buffer (containing 150 mM NaCl, 50 mM Tris (pH 8.0), and 0.1% Tween20) for 1 hour at room temperature. We used following primary antibodies diluted in TNT buffer; anti-Cx43 C-terminus (1:2000, Sigma-Aldrich), anti-DRP1 (1:500, Abcam), anti-phospho-DRP1 at S616 (1:1000, Cell Signaling Technology, Danvers, MA), anti-phospho-DRP1 at S637 (1:1000, Cell Signaling Technology), anti-MFN1 (1:1000, Cell Signaling Technology), anti-MFN2 (1:1000, Abcam), anti-TOM20 (1:500, Santa Cruz, Dallas, TX), anti-Tubulin (1:2000, Abcam, Cambridge, United Kingdom), anti-GFP (1:10000, Abcam), anti-PGC-1α (1:500, Novus Biologicals, Littleton, CO), anti-mtTFA (1:1000, Abcam), anti-LC3B (1:3000, Abcam), anti-DNM2 (1:1000, Abcam), anti-actin (1:2000, Sigma-Aldrich), anti-COX IV (1:1000, Abcam), and anti-MEK1/2 (1:1000, Cell Signaling Technology). After overnight primary antibody incubation at 4°C, the membrane was washed with TNT buffer 3 × 10 min and incubated with host-matched immunoglobin cross-adsorbed secondary antibodies conjugated with Alexa Fluor 488, 555, 647 (1:500, Thermo Fisher Scientific) diluted in TNT buffer for 1 hour at room temperature. The membrane was washed with TNT buffer 3 × 10 min, soaked in methanol, and air dried followed by the band detection using Chemidoc MP imaging system (Bio-Rad). The band intensity was quantified using Image Lab software (Bio-Rad).</p></sec><sec id="s4-6"><title>Protein purification</title><p>GJA1-20k without the putative transmembrane region (amino acids 236 - 382 of the full-length human Cx43, NCBI reference NP 000156,1) was fused at the N-terminus with a 6 × His tag and a linker, and at the C-terminus with a linker and 10 Aspartic Acids. The fusion construct was cloned into the pET301/CT-DEST vector via Gateway cloning (Thermo Fisher Scientific). The primers to amplify the sequence are: Forward primer: 5' <named-content content-type="sequence">GGGGACAAGTTTGTACAAAAAAGCAGGCTTCAGGAGGTATACATATGCATCATCATCATCATCACGGTGGTGGCGGTTCAGGCGGAGGTGGCTCTGTTAAGGATCGGGTTAAGGGAAAG</named-content> 3'. Reverse primer: 5' <named-content content-type="sequence">GGGGACCACTTTGTACAAGAAAGCTGGGTCTTACTAATCGTCATCATCGTCATCATCGTCATCATCACTTCCACCACTTCCACCGATCTCCAGGTCATCAGGCCG</named-content> 3'. The fusion protein was expressed in the <italic>E. coli</italic> expression strain LOBSTR (<xref ref-type="bibr" rid="bib1">Andersen et al., 2013</xref>) (Kerafast, Boston, MA) transformed with pTf16, which encodes the chaperone protein tag (TaKaRa Bio, Shiga, Japan), following the manufacturer protocol. Protein expression was induced at 37°C with 1 mM isopropyl-1-thio-β-galactopyranoside. The bacterial pellet containing induced GJA1-20k was lysed in B-PER Bacterial Protein Extraction Reagent (Thermo Fisher Scientific) containing cOmplete ULTRA Protease Inhibitor Tablets (Sigma-Aldrich) and sonicated and centrifuged to separate soluble proteins. The HisPur Cobalt Purification Kit (Thermo Fisher Scientific) was used to purify the protein following the manufacturer protocol with some buffer substitutions. We used a buffer containing 300 mM NaCl, 50 mM NaH<sub>2</sub>PO<sub>4</sub>, 5 mM 2-mercaptoethanol, pH 8.0 for column equilibration and washing (with addition of 10 mM and 20 mM imidazole for sequential washing steps), and we used an elution buffer containing 300 mM NaCl, 50 mM NaH<sub>2</sub>PO<sub>4</sub>, 150 mM Imidazole, pH 8.0, 10% glycerol. Before use, the purified protein was concentrated and subjected to a buffer exchange into a final buffer containing 50 mM NaH<sub>2</sub>PO<sub>4</sub>, 150 mM NaCl (pH 8.0) with 10% glycerol.</p></sec><sec id="s4-7"><title>Cell-free pyrene-actin polymerization and depolymerization assay</title><p>The pyrene-actin polymerization and depolymerization assays were performed using the Actin Polymerization Biochem Kit (Cytoskeleton, Inc, Denver, CO) following the manufacturer protocol. Briefly, lyophilized pyrene-conjugated skeletal muscle actin was reconstituted and diluted to a concentration of 1 mg/ml in G-Buffer (5 mM Tris-HCl pH 8.0, 0.2 mM CaCl<sub>2</sub>, 0.2 mM ATP) and polymerized with 0.25× Actin Polymerization Buffer (500 mM KCl, 20 mM MgCl<sub>2</sub>, 50 mM guanidine carbonate, 10 mM ATP) for 1 hr at room temperature. F-actin was incubated with either 15 nM LatA or an equal volume of DMSO, and/or 1 mM GJA1-20k protein purified as described above. For the polymerization assay, actin was incubated with 1 mM GJA1-20k protein before polymerization. The changes in fluorescence were measured in microplate reader (FlexStation 3, Molecular Devices, San Jose, CA) at excitation wavelength 365 nm and emission wavelength 407 nm. The data was obtained from duplicate or triplicate experimental repeats.</p></sec><sec id="s4-8"><title>Seahorse mitochondrial respiration assay</title><p>The mitochondrial oxygen consumption rate (OCR) was measured using Seahorse XF96 analyzer (Agilent, Santa Clara, CA) following the manufacturer protocol and previous study (<xref ref-type="bibr" rid="bib66">Zhang et al., 2012</xref>). Isolated mouse neonatal cardiomyocytes (CM) described above (8.0 × 10<sup>4</sup> cells/well) or GST- or GJA1-20k-transfected HEK293 cells (1.0 × 10<sup>4</sup> cells/well) were seeded into Seahorse XF96 plate. Before seeding neonatal CM, the plate was coated by laminin (20 μg/ml). After 1 (HEK293) or 2 days (neonatal CM) incubation at 37°C, OCR was measured in three time points after injection of oligomycin (2 μM for neonatal CM; 1 μM for HEK293), arbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP; 5 μM for neonatal CM; 1.5 μM for HEK293), and rotenone/antimycin A (R/A; 1 μM each for both neonatal CM and HEK293). The data was normalized by protein concentration in each well. The maximum respiration was calculated by subtracting the third measurement point of R/A treatment from that of FCCP treatment. For basal respiration, we calculated the difference between the third measurement during the pre-oligomycin phase and the third measurement post-R/A. For proton leak, we calculated the difference between the third measurement during the post-oligomycin and the third measurement post-R/A. For maximum respiration, we calculated the difference between the third measurement during the post-FCCP and the third measurement post-R/A. For ATP-linked respiration, we calculated the difference between the third measurement during the pre-oligomycin phase and the third measurement post-oligomycin. For reserve capacity, we calculated the difference between the third measurement during the post-FCCP and the third measurement the pre-oligomycin phase. For non-mitochondrial respiration, we used the value at the third measurement post-R/A.</p></sec><sec id="s4-9"><title>Mitochondrial ROS measurement</title><p>The cells were harvested in 35 mm glass-bottomed dish and transfected plasmid as described above. The samples were treated with H<sub>2</sub>O<sub>2</sub> (600 μM, Sigma-Aldrich) or PBS as control diluted in culture medium for 30 min at 37°C followed by MitoSOX Red Mitochondrial Superoxide Indicator (5 μM, Thermo Fisher Scientific) for 10 min at 37°C or CellROX Deep Red (5 μM, Thermo Fisher Scientific) for 30 min at 37°C. After the incubation, the samples were subjected to live cell imaging. The intensity was calculated using the formula; Total cell intensity – (Area of the cell× Mean intensity of background) by Image J.</p></sec><sec id="s4-10"><title>Langendorff-perfused mouse heart I/R injury</title><p>Adult (14- to 16-week-old) male WT or Gja1<sup>M213L/WT</sup> mice were used for I/R study, as previously described (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>) with some modifications. Briefly, mice were injected with 100 U (IP) of heparin 20 min prior to IP administration of sodium pentobarbital (200 mg/kg) and hearts were removed quickly by a midsternal incision and placed into ice-cold modified pH 7.4 Krebs-Henseleit (K-H) solution. Then, the heart was attached to Langendorff apparatus, and perfused through the aorta at a constant rate 2.5 ml/min with the Krebs-Henseleit (K-H) solution (pH 7.4) gassed with 95% O<sub>2</sub>/5% CO<sub>2</sub> constantly. The K-H solution temperature was maintained at 37°C by circulating water bath. After 20 min equilibration to achieve a steady state, the hearts were subjected to 30 min of ischemia (no-flow ischemia) followed by 60 minutes of reperfusion. During ischemia, the hearts were immersed in warm K-H solution. After reperfusion, the hearts were sliced in 1 mm thickness and immersed in freshly made 1 % triphenyl tetrazolium chloride (TTC) solution for 20 minutes at 37 °C followed by fixation with 4 % paraformaldehyde for 30 min. Scanned image was analyzed using Image J (NIH). The area of the infarcted region of each slice was measured by semiautomatic threshold color setting, and expressed as a percentage of the total slice area. Infarct size was corrected to the weight of each slice as previously described (<xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref>). For dihydroethidium (DHE; Thermo Fisher Scientific) staining, the heart sections embedded in OCT compound were made in 10 μm and wash with PBS 2 × 5 min followed by 20 min incubation with 5 μM of DHE at 37 °C. After repeat washing step with PBS, the sections were mounted by ProLong Gold Antifade Mountant with DAPI (Thermo Fisher Scientific) and subjected to fluorescent imaging.</p></sec><sec id="s4-11"><title>Mitochondrial DNA copy number analysis</title><p>Total DNA was extracted using NucleoSpin Tissue (MACHEREY-NAGEL, Düren, Germany) from the mouse hearts or the cells cultured in six-well plate following manufacturer protocol. The DNA concentration was measured using NanoDrop 2000 (Thermo Fisher Scientific) and 5 ng/μl of DNA was subjected to Real-Time PCR analysis (Bio-Rad) using Mouse Mitochondrial DNA Copy Number Assay kit (Detroit R&amp;D, Detroit, MI) for the samples from the mouse heart or Human Mitochondrial DNA Monitoring Primer Set (TaKaRa Bio) for the cells following manufacturer protocol.</p></sec><sec id="s4-12"><title>ATP measurement</title><p>GST- or GJA1-20k-transfected HEK293 cells (1.0 × 10<sup>4</sup> cells/well) were seeded into white 96-well microplate (PerkinElmer, Waltham, MA). ATP measurement was performed using ATPlite Luminescence Assay System (PerkinElmer) following manufacturer protocol and the luminescence was measured in microplate reader (FlexStation 3, Molecular Devices). Note that the cells were washed with PBS before adding lysis buffer and 10 μl of the lysate was used for protein concentration measurement as described above. The result of ATP amount was normalized by total protein amount in each well.</p></sec><sec id="s4-13"><title>Statistical analysis</title><p>Graphs were created and analyzed using Prism six software (GraphPad). For two groups comparison, unpaired two-tail Mann-Whitney U-test was performed. For among multiple group comparison, Kruskal-Wallis test with Dunn’s post-hoc test or two-way ANOVA with Bonferroni’s post-hoc test was performed. p values of less than 0.05 was considered significant. All data points, exact p values, and statistical data are provided in the source data.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Methodology, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Methodology, Supervision</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal care and study protocols were approved by University of Utah Institutional Animal Care and Use Committee (#19-09010).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69207-transrepform1-v1.pdf"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Uncropped membranes for all western blots in the manuscript.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-69207-supp1-v1.zip"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The data supporting the findings of this study are available within the paper and its source data files. Plasmids are available at the non-profit plasmid repository Addgene, under Robin Shaw Lab.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We acknowledge W Basheer and D Hernandez for the technical discussion, S Ryazantsev and L Nikolova for electron microscopy, A Laxman for Seahorse analysis. JR is an Investigator of the Howard Hughes Medical Institute.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>KR</given-names></name><name><surname>Leksa</surname><given-names>NC</given-names></name><name><surname>Schwartz</surname><given-names>TU</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Optimized <italic>E. coli</italic> expression strain LOBSTR eliminates common contaminants from His-tag purification</article-title><source>Proteins</source><volume>81</volume><fpage>1857</fpage><lpage>1861</lpage><pub-id pub-id-type="doi">10.1002/prot.24364</pub-id><pub-id pub-id-type="pmid">23852738</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atar</surname><given-names>D</given-names></name><name><surname>Arheden</surname><given-names>H</given-names></name><name><surname>Berdeaux</surname><given-names>A</given-names></name><name><surname>Bonnet</surname><given-names>JL</given-names></name><name><surname>Carlsson</surname><given-names>M</given-names></name><name><surname>Clemmensen</surname><given-names>P</given-names></name><name><surname>Cuvier</surname><given-names>V</given-names></name><name><surname>Danchin</surname><given-names>N</given-names></name><name><surname>Dubois-Rande</surname><given-names>JL</given-names></name><name><surname>Engblom</surname><given-names>H</given-names></name><name><surname>Erlinge</surname><given-names>D</given-names></name><name><surname>Firat</surname><given-names>H</given-names></name><name><surname>Halvorsen</surname><given-names>S</given-names></name><name><surname>Hansen</surname><given-names>HS</given-names></name><name><surname>Hauke</surname><given-names>W</given-names></name><name><surname>Heiberg</surname><given-names>E</given-names></name><name><surname>Koul</surname><given-names>S</given-names></name><name><surname>Larsen</surname><given-names>AI</given-names></name><name><surname>Le Corvoisier</surname><given-names>P</given-names></name><name><surname>Nordrehaug</surname><given-names>JE</given-names></name><name><surname>Paganelli</surname><given-names>F</given-names></name><name><surname>Pruss</surname><given-names>RM</given-names></name><name><surname>Rousseau</surname><given-names>H</given-names></name><name><surname>Schaller</surname><given-names>S</given-names></name><name><surname>Sonou</surname><given-names>G</given-names></name><name><surname>Tuseth</surname><given-names>V</given-names></name><name><surname>Veys</surname><given-names>J</given-names></name><name><surname>Vicaut</surname><given-names>E</given-names></name><name><surname>Jensen</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results</article-title><source>European Heart Journal</source><volume>36</volume><fpage>112</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehu331</pub-id><pub-id pub-id-type="pmid">25179768</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basheer</surname><given-names>WA</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Epifantseva</surname><given-names>I</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Kleber</surname><given-names>AG</given-names></name><name><surname>Hong</surname><given-names>T</given-names></name><name><surname>Shaw</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>GJA1-20k Arranges Actin to Guide Cx43 Delivery to Cardiac Intercalated Discs</article-title><source>Circulation Research</source><volume>121</volume><fpage>1069</fpage><lpage>1080</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.311955</pub-id><pub-id pub-id-type="pmid">28923791</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basheer</surname><given-names>WA</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Shimura</surname><given-names>D</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Agvanian</surname><given-names>S</given-names></name><name><surname>Hernandez</surname><given-names>DM</given-names></name><name><surname>Hitzeman</surname><given-names>TC</given-names></name><name><surname>Hong</surname><given-names>T</given-names></name><name><surname>Shaw</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Stress response protein GJA1-20k promotes mitochondrial biogenesis, metabolic quiescence, and cardioprotection against ischemia/reperfusion injury</article-title><source>JCI Insight</source><volume>3</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.121900</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanchoin</surname><given-names>L</given-names></name><name><surname>Boujemaa-Paterski</surname><given-names>R</given-names></name><name><surname>Sykes</surname><given-names>C</given-names></name><name><surname>Plastino</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Actin dynamics, architecture, and mechanics in cell motility</article-title><source>Physiological Reviews</source><volume>94</volume><fpage>235</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1152/physrev.00018.2013</pub-id><pub-id pub-id-type="pmid">24382887</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgers</surname><given-names>M</given-names></name><name><surname>Thone</surname><given-names>F</given-names></name><name><surname>Wouters</surname><given-names>L</given-names></name><name><surname>Ausma</surname><given-names>J</given-names></name><name><surname>Shivalkar</surname><given-names>B</given-names></name><name><surname>Flameng</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Structural Correlates of Regional Myocardial Dysfunction in Patients with Critical Coronary-Artery Stenosis - Chronic Hibernation</article-title><source>Cardiovascular Pathology</source><volume>2</volume><fpage>237</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/1054-8807(93)90030-6</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgers</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Hibernating myocardium: Programmed cell survival or programmed cell death</article-title><source>Experimental and Clinical Cardiology</source><volume>7</volume><fpage>69</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">19649226</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JR</given-names></name><name><surname>Malenka</surname><given-names>DJ</given-names></name><name><surname>DeVries</surname><given-names>JT</given-names></name><name><surname>Robb</surname><given-names>JF</given-names></name><name><surname>Jayne</surname><given-names>JE</given-names></name><name><surname>Friedman</surname><given-names>BJ</given-names></name><name><surname>Hettleman</surname><given-names>BD</given-names></name><name><surname>Niles</surname><given-names>NW</given-names></name><name><surname>Kaplan</surname><given-names>AV</given-names></name><name><surname>Schoolwerth</surname><given-names>AC</given-names></name><name><surname>Thompson</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry</article-title><source>Catheterization and Cardiovascular Interventions</source><volume>72</volume><fpage>347</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1002/ccd.21619</pub-id><pub-id pub-id-type="pmid">18729173</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burman</surname><given-names>JL</given-names></name><name><surname>Pickles</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Sekine</surname><given-names>S</given-names></name><name><surname>Vargas</surname><given-names>JNS</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Youle</surname><given-names>AM</given-names></name><name><surname>Nezich</surname><given-names>CL</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Hammer</surname><given-names>JA</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mitochondrial fission facilitates the selective mitophagy of protein aggregates</article-title><source>The Journal of Cell Biology</source><volume>216</volume><fpage>3231</fpage><lpage>3247</lpage><pub-id pub-id-type="doi">10.1083/jcb.201612106</pub-id><pub-id pub-id-type="pmid">28893839</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mitochondria: dynamic organelles in disease, aging, and development</article-title><source>Cell</source><volume>125</volume><fpage>1241</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.06.010</pub-id><pub-id pub-id-type="pmid">16814712</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coronado</surname><given-names>M</given-names></name><name><surname>Fajardo</surname><given-names>G</given-names></name><name><surname>Nguyen</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Kooiker</surname><given-names>K</given-names></name><name><surname>Jung</surname><given-names>G</given-names></name><name><surname>Hu</surname><given-names>DQ</given-names></name><name><surname>Reddy</surname><given-names>S</given-names></name><name><surname>Sandoval</surname><given-names>E</given-names></name><name><surname>Stotland</surname><given-names>A</given-names></name><name><surname>Gottlieb</surname><given-names>RA</given-names></name><name><surname>Bernstein</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Physiological Mitochondrial Fragmentation Is a Normal Cardiac Adaptation to Increased Energy Demand</article-title><source>Circulation Research</source><volume>122</volume><fpage>282</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.310725</pub-id><pub-id pub-id-type="pmid">29233845</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cung</surname><given-names>TT</given-names></name><name><surname>Morel</surname><given-names>O</given-names></name><name><surname>Cayla</surname><given-names>G</given-names></name><name><surname>Rioufol</surname><given-names>G</given-names></name><name><surname>Garcia-Dorado</surname><given-names>D</given-names></name><name><surname>Angoulvant</surname><given-names>D</given-names></name><name><surname>Bonnefoy-Cudraz</surname><given-names>E</given-names></name><name><surname>Guerin</surname><given-names>P</given-names></name><name><surname>Elbaz</surname><given-names>M</given-names></name><name><surname>Delarche</surname><given-names>N</given-names></name><name><surname>Coste</surname><given-names>P</given-names></name><name><surname>Vanzetto</surname><given-names>G</given-names></name><name><surname>Metge</surname><given-names>M</given-names></name><name><surname>Aupetit</surname><given-names>JF</given-names></name><name><surname>Jouve</surname><given-names>B</given-names></name><name><surname>Motreff</surname><given-names>P</given-names></name><name><surname>Tron</surname><given-names>C</given-names></name><name><surname>Labeque</surname><given-names>JN</given-names></name><name><surname>Steg</surname><given-names>PG</given-names></name><name><surname>Cottin</surname><given-names>Y</given-names></name><name><surname>Range</surname><given-names>G</given-names></name><name><surname>Clerc</surname><given-names>J</given-names></name><name><surname>Claeys</surname><given-names>MJ</given-names></name><name><surname>Coussement</surname><given-names>P</given-names></name><name><surname>Prunier</surname><given-names>F</given-names></name><name><surname>Moulin</surname><given-names>F</given-names></name><name><surname>Roth</surname><given-names>O</given-names></name><name><surname>Belle</surname><given-names>L</given-names></name><name><surname>Dubois</surname><given-names>P</given-names></name><name><surname>Barragan</surname><given-names>P</given-names></name><name><surname>Gilard</surname><given-names>M</given-names></name><name><surname>Piot</surname><given-names>C</given-names></name><name><surname>Colin</surname><given-names>P</given-names></name><name><surname>De Poli</surname><given-names>F</given-names></name><name><surname>Morice</surname><given-names>MC</given-names></name><name><surname>Ider</surname><given-names>O</given-names></name><name><surname>Dubois-Rande</surname><given-names>JL</given-names></name><name><surname>Unterseeh</surname><given-names>T</given-names></name><name><surname>Le Breton</surname><given-names>H</given-names></name><name><surname>Beard</surname><given-names>T</given-names></name><name><surname>Blanchard</surname><given-names>D</given-names></name><name><surname>Grollier</surname><given-names>G</given-names></name><name><surname>Malquarti</surname><given-names>V</given-names></name><name><surname>Staat</surname><given-names>P</given-names></name><name><surname>Sudre</surname><given-names>A</given-names></name><name><surname>Elmer</surname><given-names>E</given-names></name><name><surname>Hansson</surname><given-names>MJ</given-names></name><name><surname>Bergerot</surname><given-names>C</given-names></name><name><surname>Boussaha</surname><given-names>I</given-names></name><name><surname>Jossan</surname><given-names>C</given-names></name><name><surname>Derumeaux</surname><given-names>G</given-names></name><name><surname>Mewton</surname><given-names>N</given-names></name><name><surname>Ovize</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cyclosporine before PCI in Patients with Acute Myocardial Infarction</article-title><source>The New England Journal of Medicine</source><volume>373</volume><fpage>1021</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1505489</pub-id><pub-id pub-id-type="pmid">26321103</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dagda</surname><given-names>RK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>13843</fpage><lpage>13855</lpage><pub-id pub-id-type="doi">10.1074/jbc.M808515200</pub-id><pub-id pub-id-type="pmid">19279012</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragasis</surname><given-names>S</given-names></name><name><surname>Bassiakou</surname><given-names>E</given-names></name><name><surname>Iacovidou</surname><given-names>N</given-names></name><name><surname>Papadimitriou</surname><given-names>L</given-names></name><name><surname>Andreas Steen</surname><given-names>P</given-names></name><name><surname>Gulati</surname><given-names>A</given-names></name><name><surname>Xanthos</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The role of opioid receptor agonists in ischemic preconditioning</article-title><source>European Journal of Pharmacology</source><volume>720</volume><fpage>401</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2013.10.001</pub-id><pub-id pub-id-type="pmid">24120367</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>TB</given-names></name><name><surname>Sánchez-Guerrero</surname><given-names>Á</given-names></name><name><surname>Milosevic</surname><given-names>I</given-names></name><name><surname>Raimundo</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mitochondrial fission requires DRP1 but not dynamins</article-title><source>Nature</source><volume>570</volume><fpage>E34</fpage><lpage>E42</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1296-y</pub-id><pub-id pub-id-type="pmid">31217603</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>JR</given-names></name><name><surname>Lackner</surname><given-names>LL</given-names></name><name><surname>West</surname><given-names>M</given-names></name><name><surname>DiBenedetto</surname><given-names>JR</given-names></name><name><surname>Nunnari</surname><given-names>J</given-names></name><name><surname>Voeltz</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>ER tubules mark sites of mitochondrial division</article-title><source>Science</source><volume>334</volume><fpage>358</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1126/science.1207385</pub-id><pub-id pub-id-type="pmid">21885730</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>JR</given-names></name><name><surname>Nunnari</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitochondrial form and function</article-title><source>Nature</source><volume>505</volume><fpage>335</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1038/nature12985</pub-id><pub-id pub-id-type="pmid">24429632</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>SS</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Basheer</surname><given-names>WA</given-names></name><name><surname>Baum</surname><given-names>R</given-names></name><name><surname>Epifantseva</surname><given-names>I</given-names></name><name><surname>Hong</surname><given-names>T</given-names></name><name><surname>Shaw</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cx43 Isoform GJA1-20k Promotes Microtubule Dependent Mitochondrial Transport</article-title><source>Frontiers in Physiology</source><volume>8</volume><elocation-id>905</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2017.00905</pub-id><pub-id pub-id-type="pmid">29163229</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>YL</given-names></name><name><surname>Tao</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>FH</given-names></name><name><surname>Zheng</surname><given-names>NZ</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Cai</surname><given-names>SY</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2020">2020</year><source>GJA1-20k Attenuates Ang II-Induced Pathological Cardiac Hypertrophy by Regulating Gap Junction Formation and Mitochondrial Function</source><publisher-name>Acta Pharmacol Sin</publisher-name></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>I</given-names></name><name><surname>Zweifel</surname><given-names>ME</given-names></name><name><surname>Courtemanche</surname><given-names>N</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Latrunculin A Accelerates Actin Filament Depolymerization in Addition to Sequestering Actin Monomers</article-title><source>Current Biology</source><volume>28</volume><fpage>3183</fpage><lpage>3192</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2018.07.082</pub-id><pub-id pub-id-type="pmid">30270183</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Dorado</surname><given-names>D</given-names></name><name><surname>Rodriguez-Sinovas</surname><given-names>A</given-names></name><name><surname>Ruiz-Meana</surname><given-names>M</given-names></name><name><surname>Inserte</surname><given-names>J</given-names></name><name><surname>Agullo</surname><given-names>L</given-names></name><name><surname>Cabestrero</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion</article-title><source>Cardiovascular Research</source><volume>70</volume><fpage>274</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2006.02.011</pub-id><pub-id pub-id-type="pmid">16635642</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garlid</surname><given-names>KD</given-names></name><name><surname>Costa</surname><given-names>AD</given-names></name><name><surname>Quinlan</surname><given-names>CL</given-names></name><name><surname>Pierre</surname><given-names>SV</given-names></name><name><surname>Dos Santos</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cardioprotective signaling to mitochondria</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>46</volume><fpage>858</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2008.11.019</pub-id><pub-id pub-id-type="pmid">19118560</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>CM</given-names></name><name><surname>Giugliano</surname><given-names>RP</given-names></name><name><surname>Kloner</surname><given-names>RA</given-names></name><name><surname>Bode</surname><given-names>C</given-names></name><name><surname>Tendera</surname><given-names>M</given-names></name><name><surname>Janosi</surname><given-names>A</given-names></name><name><surname>Merkely</surname><given-names>B</given-names></name><name><surname>Godlewski</surname><given-names>J</given-names></name><name><surname>Halaby</surname><given-names>R</given-names></name><name><surname>Korjian</surname><given-names>S</given-names></name><name><surname>Daaboul</surname><given-names>Y</given-names></name><name><surname>Chakrabarti</surname><given-names>AK</given-names></name><name><surname>Spielman</surname><given-names>K</given-names></name><name><surname>Neal</surname><given-names>BJ</given-names></name><name><surname>Weaver</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention</article-title><source>European Heart Journal</source><volume>37</volume><fpage>1296</fpage><lpage>1303</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehv597</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatch</surname><given-names>AL</given-names></name><name><surname>Gurel</surname><given-names>PS</given-names></name><name><surname>Higgs</surname><given-names>HN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Novel roles for actin in mitochondrial fission</article-title><source>Journal of Cell Science</source><volume>127</volume><fpage>4549</fpage><lpage>4560</lpage><pub-id pub-id-type="doi">10.1242/jcs.153791</pub-id><pub-id pub-id-type="pmid">25217628</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinzel</surname><given-names>FR</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Boengler</surname><given-names>K</given-names></name><name><surname>Buechert</surname><given-names>A</given-names></name><name><surname>Garcia-Dorado</surname><given-names>D</given-names></name><name><surname>Di Lisa</surname><given-names>F</given-names></name><name><surname>Schulz</surname><given-names>R</given-names></name><name><surname>Heusch</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice</article-title><source>Circulation Research</source><volume>97</volume><fpage>583</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000181171.65293.65</pub-id><pub-id pub-id-type="pmid">16100048</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heusch</surname><given-names>G</given-names></name><name><surname>Musiolik</surname><given-names>J</given-names></name><name><surname>Gedik</surname><given-names>N</given-names></name><name><surname>Skyschally</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion</article-title><source>Circulation Research</source><volume>109</volume><fpage>1302</fpage><lpage>1308</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.255604</pub-id><pub-id pub-id-type="pmid">21980124</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heusch</surname><given-names>G</given-names></name><name><surname>Gersh</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge</article-title><source>European Heart Journal</source><volume>38</volume><fpage>774</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehw224</pub-id><pub-id pub-id-type="pmid">27354052</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heusch</surname><given-names>G</given-names></name><name><surname>Gersh</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Is Cardioprotection Salvageable</article-title><source>Circulation</source><volume>141</volume><fpage>415</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.119.044176</pub-id><pub-id pub-id-type="pmid">32078426</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Drp1-Dependent Mitochondrial Fission Plays Critical Roles in Physiological and Pathological Progresses in Mammals</article-title><source>International Journal of Molecular Sciences</source><volume>18</volume><elocation-id>E144</elocation-id><pub-id pub-id-type="doi">10.3390/ijms18010144</pub-id><pub-id pub-id-type="pmid">28098754</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Shirakabe</surname><given-names>A</given-names></name><name><surname>Maejima</surname><given-names>Y</given-names></name><name><surname>Zhai</surname><given-names>P</given-names></name><name><surname>Sciarretta</surname><given-names>S</given-names></name><name><surname>Toli</surname><given-names>J</given-names></name><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Mihara</surname><given-names>K</given-names></name><name><surname>Egashira</surname><given-names>K</given-names></name><name><surname>Ohishi</surname><given-names>M</given-names></name><name><surname>Abdellatif</surname><given-names>M</given-names></name><name><surname>Sadoshima</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress</article-title><source>Circulation Research</source><volume>116</volume><fpage>264</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.303356</pub-id><pub-id pub-id-type="pmid">25332205</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>W</given-names></name><name><surname>Hatch</surname><given-names>AL</given-names></name><name><surname>Merrill</surname><given-names>RA</given-names></name><name><surname>Strack</surname><given-names>S</given-names></name><name><surname>Higgs</surname><given-names>HN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Actin filaments target the oligomeric maturation of the dynamin gtpase drp1 to mitochondrial fission sites</article-title><source>eLife</source><volume>4</volume><elocation-id>e11553</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.11553</pub-id><pub-id pub-id-type="pmid">26609810</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juhaszova</surname><given-names>M</given-names></name><name><surname>Zorov</surname><given-names>DB</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Pepe</surname><given-names>S</given-names></name><name><surname>Fu</surname><given-names>Q</given-names></name><name><surname>Fishbein</surname><given-names>KW</given-names></name><name><surname>Ziman</surname><given-names>BD</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Ytrehus</surname><given-names>K</given-names></name><name><surname>Antos</surname><given-names>CL</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name><name><surname>Sollott</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore</article-title><source>The Journal of Clinical Investigation</source><volume>113</volume><fpage>1535</fpage><lpage>1549</lpage><pub-id pub-id-type="doi">10.1172/JCI19906</pub-id><pub-id pub-id-type="pmid">15173880</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korobova</surname><given-names>F</given-names></name><name><surname>Ramabhadran</surname><given-names>V</given-names></name><name><surname>Higgs</surname><given-names>HN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2</article-title><source>Science</source><volume>339</volume><fpage>464</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1126/science.1228360</pub-id><pub-id pub-id-type="pmid">23349293</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Westrate</surname><given-names>LM</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Page</surname><given-names>C</given-names></name><name><surname>Voeltz</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Multiple dynamin family members collaborate to drive mitochondrial division</article-title><source>Nature</source><volume>540</volume><fpage>139</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1038/nature20555</pub-id><pub-id pub-id-type="pmid">27798601</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>GB</given-names></name><name><surname>Zhang</surname><given-names>HW</given-names></name><name><surname>Fu</surname><given-names>RQ</given-names></name><name><surname>Hu</surname><given-names>XY</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>YN</given-names></name><name><surname>Liu</surname><given-names>YX</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>JJ</given-names></name><name><surname>Deng</surname><given-names>Q</given-names></name><name><surname>Luo</surname><given-names>QS</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Gao</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitochondrial fission and mitophagy depend on cofilin-mediated actin depolymerization activity at the mitochondrial fission site</article-title><source>Oncogene</source><volume>37</volume><fpage>1485</fpage><lpage>1502</lpage><pub-id pub-id-type="doi">10.1038/s41388-017-0064-4</pub-id><pub-id pub-id-type="pmid">29321664</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKhann</surname><given-names>GM</given-names></name><name><surname>Grega</surname><given-names>MA</given-names></name><name><surname>Borowicz</surname><given-names>LM</given-names><suffix>Jr</suffix></name><name><surname>Baumgartner</surname><given-names>WA</given-names></name><name><surname>Selnes</surname><given-names>OA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Stroke and encephalopathy after cardiac surgery: An update</article-title><source>Stroke</source><volume>37</volume><fpage>562</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000199032.78782.6c</pub-id><pub-id pub-id-type="pmid">16373636</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>AS</given-names></name><name><surname>Wong</surname><given-names>YC</given-names></name><name><surname>Simpson</surname><given-names>CL</given-names></name><name><surname>Holzbaur</surname><given-names>EL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dynamic actin cycling through mitochondrial subpopulations locally regulates the fission-fusion balance within mitochondrial networks</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12886</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12886</pub-id><pub-id pub-id-type="pmid">27686185</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murry</surname><given-names>CE</given-names></name><name><surname>Jennings</surname><given-names>RB</given-names></name><name><surname>Reimer</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium</article-title><source>Circulation</source><volume>74</volume><fpage>1124</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1161/01.cir.74.5.1124</pub-id><pub-id pub-id-type="pmid">3769170</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>A</given-names></name><name><surname>Shimauchi</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Shimoda</surname><given-names>K</given-names></name><name><surname>Toyama</surname><given-names>T</given-names></name><name><surname>Kitajima</surname><given-names>N</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Shindo</surname><given-names>N</given-names></name><name><surname>Numaga-Tomita</surname><given-names>T</given-names></name><name><surname>Yasuda</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Kuwahara</surname><given-names>K</given-names></name><name><surname>Kumagai</surname><given-names>Y</given-names></name><name><surname>Akaike</surname><given-names>T</given-names></name><name><surname>Ide</surname><given-names>T</given-names></name><name><surname>Ojida</surname><given-names>A</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Nishida</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hypoxia-induced interaction of filamin with drp1 causes mitochondrial hyperfission-associated myocardial senescence</article-title><source>Science Signaling</source><volume>11</volume><elocation-id>eaat5185</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aat5185</pub-id><pub-id pub-id-type="pmid">30425165</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunnari</surname><given-names>J</given-names></name><name><surname>Suomalainen</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitochondria: in sickness and in health</article-title><source>Cell</source><volume>148</volume><fpage>1145</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.02.035</pub-id><pub-id pub-id-type="pmid">22424226</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Neal</surname><given-names>JB</given-names></name><name><surname>Shaw</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Acute kidney injury following cardiac surgery: current understanding and future directions</article-title><source>Critical Care</source><volume>20</volume><elocation-id>187</elocation-id><pub-id pub-id-type="doi">10.1186/s13054-016-1352-z</pub-id><pub-id pub-id-type="pmid">27373799</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picard</surname><given-names>M</given-names></name><name><surname>Shirihai</surname><given-names>OS</given-names></name><name><surname>Gentil</surname><given-names>BJ</given-names></name><name><surname>Burelle</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mitochondrial morphology transitions and functions: implications for retrograde signaling</article-title><source>American Journal of Physiology. Regulatory, Integrative and Comparative Physiology</source><volume>304</volume><fpage>R393</fpage><lpage>R406</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00584.2012</pub-id><pub-id pub-id-type="pmid">23364527</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>D</given-names></name><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zou</surname><given-names>S</given-names></name><name><surname>Hong</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Overexpression of Astrocytes-Specific GJA1-20k Enhances the Viability and Recovery of the Neurons in a Rat Model of Traumatic Brain Injury</article-title><source>ACS Chemical Neuroscience</source><volume>11</volume><fpage>1643</fpage><lpage>1650</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.0c00142</pub-id><pub-id pub-id-type="pmid">32401478</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roach</surname><given-names>GW</given-names></name><name><surname>Kanchuger</surname><given-names>M</given-names></name><name><surname>Mangano</surname><given-names>CM</given-names></name><name><surname>Newman</surname><given-names>M</given-names></name><name><surname>Nussmeier</surname><given-names>N</given-names></name><name><surname>Wolman</surname><given-names>R</given-names></name><name><surname>Aggarwal</surname><given-names>A</given-names></name><name><surname>Marschall</surname><given-names>K</given-names></name><name><surname>Graham</surname><given-names>SH</given-names></name><name><surname>Ley</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Adverse cerebral outcomes after coronary bypass surgery Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators</article-title><source>The New England Journal of Medicine</source><volume>335</volume><fpage>1857</fpage><lpage>1863</lpage><pub-id pub-id-type="doi">10.1056/NEJM199612193352501</pub-id><pub-id pub-id-type="pmid">8948560</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Sinovas</surname><given-names>A</given-names></name><name><surname>Ruiz-Meana</surname><given-names>M</given-names></name><name><surname>Denuc</surname><given-names>A</given-names></name><name><surname>Garcia-Dorado</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitochondrial Cx43, an important component of cardiac preconditioning</article-title><source>Biochim Biophys Acta Biomembr</source><volume>1860</volume><fpage>174</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2017.06.011</pub-id><pub-id pub-id-type="pmid">28642043</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabouny</surname><given-names>R</given-names></name><name><surname>Shutt</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reciprocal Regulation of Mitochondrial Fission and Fusion</article-title><source>Trends in Biochemical Sciences</source><volume>45</volume><fpage>564</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2020.03.009</pub-id><pub-id pub-id-type="pmid">32291139</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salat-Canela</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Internal translation of the connexin 43 transcript</article-title><source>Cell Communication and Signaling</source><volume>12</volume><elocation-id>31</elocation-id><pub-id pub-id-type="doi">10.1186/1478-811X-12-31</pub-id><pub-id pub-id-type="pmid">24884945</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaller</surname><given-names>S</given-names></name><name><surname>Paradis</surname><given-names>S</given-names></name><name><surname>Ngoh</surname><given-names>GA</given-names></name><name><surname>Assaly</surname><given-names>R</given-names></name><name><surname>Buisson</surname><given-names>B</given-names></name><name><surname>Drouot</surname><given-names>C</given-names></name><name><surname>Ostuni</surname><given-names>MA</given-names></name><name><surname>Lacapere</surname><given-names>JJ</given-names></name><name><surname>Bassissi</surname><given-names>F</given-names></name><name><surname>Bordet</surname><given-names>T</given-names></name><name><surname>Berdeaux</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>SP</given-names></name><name><surname>Morin</surname><given-names>D</given-names></name><name><surname>Pruss</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition</article-title><source>The Journal of Pharmacology and Experimental Therapeutics</source><volume>333</volume><fpage>696</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1124/jpet.110.167486</pub-id><pub-id pub-id-type="pmid">20215409</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrepfer</surname><given-names>E</given-names></name><name><surname>Scorrano</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitofusins, from Mitochondria to Metabolism</article-title><source>Molecular Cell</source><volume>61</volume><fpage>683</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.02.022</pub-id><pub-id pub-id-type="pmid">26942673</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>R</given-names></name><name><surname>Gorge</surname><given-names>PM</given-names></name><name><surname>Gorbe</surname><given-names>A</given-names></name><name><surname>Ferdinandy</surname><given-names>P</given-names></name><name><surname>Lampe</surname><given-names>PD</given-names></name><name><surname>Leybaert</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection</article-title><source>Pharmacology &amp; Therapeutics</source><volume>153</volume><fpage>90</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2015.06.005</pub-id><pub-id pub-id-type="pmid">26073311</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirakabe</surname><given-names>A</given-names></name><name><surname>Zhai</surname><given-names>P</given-names></name><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Maejima</surname><given-names>Y</given-names></name><name><surname>Hsu</surname><given-names>CP</given-names></name><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Egashira</surname><given-names>K</given-names></name><name><surname>Levine</surname><given-names>B</given-names></name><name><surname>Sadoshima</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload-Induced Mitochondrial Dysfunction and Heart Failure</article-title><source>Circulation</source><volume>133</volume><fpage>1249</fpage><lpage>1263</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.115.020502</pub-id><pub-id pub-id-type="pmid">26915633</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>JW</given-names></name><name><surname>Shaw</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Autoregulation of connexin43 gap junction formation by internally translated isoforms</article-title><source>Cell Reports</source><volume>5</volume><fpage>611</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.10.009</pub-id><pub-id pub-id-type="pmid">24210816</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>M</given-names></name><name><surname>Mihara</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Scorrano</surname><given-names>L</given-names></name><name><surname>Dorn</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts</article-title><source>Cell Metabolism</source><volume>21</volume><fpage>273</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.12.011</pub-id><pub-id pub-id-type="pmid">25600785</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sprenger</surname><given-names>HG</given-names></name><name><surname>Langer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The Good and the Bad of Mitochondrial Breakups</article-title><source>Trends in Cell Biology</source><volume>29</volume><fpage>888</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2019.08.003</pub-id><pub-id pub-id-type="pmid">31495461</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stavru</surname><given-names>F</given-names></name><name><surname>Palmer</surname><given-names>AE</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name><name><surname>Cossart</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Atypical mitochondrial fission upon bacterial infection</article-title><source>PNAS</source><volume>110</volume><fpage>16003</fpage><lpage>16008</lpage><pub-id pub-id-type="doi">10.1073/pnas.1315784110</pub-id><pub-id pub-id-type="pmid">24043775</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suen</surname><given-names>DF</given-names></name><name><surname>Norris</surname><given-names>KL</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mitochondrial dynamics and apoptosis</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>1577</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1101/gad.1658508</pub-id><pub-id pub-id-type="pmid">18559474</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tandler</surname><given-names>B</given-names></name><name><surname>Hoppel</surname><given-names>CL</given-names></name><name><surname>Mears</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Morphological Pathways of Mitochondrial Division</article-title><source>Antioxidants</source><volume>7</volume><elocation-id>E30</elocation-id><pub-id pub-id-type="doi">10.3390/antiox7020030</pub-id><pub-id pub-id-type="pmid">29462856</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tricoci</surname><given-names>P</given-names></name><name><surname>Newby</surname><given-names>LK</given-names></name><name><surname>Clare</surname><given-names>RM</given-names></name><name><surname>Leonardi</surname><given-names>S</given-names></name><name><surname>Gibson</surname><given-names>CM</given-names></name><name><surname>Giugliano</surname><given-names>RP</given-names></name><name><surname>Armstrong</surname><given-names>PW</given-names></name><name><surname>Van de Werf</surname><given-names>F</given-names></name><name><surname>Montalescot</surname><given-names>G</given-names></name><name><surname>Moliterno</surname><given-names>DJ</given-names></name><name><surname>Held</surname><given-names>C</given-names></name><name><surname>Aylward</surname><given-names>PE</given-names></name><name><surname>Wallentin</surname><given-names>L</given-names></name><name><surname>Harrington</surname><given-names>RA</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name><name><surname>Mahaffey</surname><given-names>KW</given-names></name><name><surname>White</surname><given-names>HD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention</article-title><source>JACC. Cardiovascular Interventions</source><volume>11</volume><fpage>856</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1016/j.jcin.2018.02.006</pub-id><pub-id pub-id-type="pmid">29747915</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ul-Hussain</surname><given-names>M</given-names></name><name><surname>Olk</surname><given-names>S</given-names></name><name><surname>Schoenebeck</surname><given-names>B</given-names></name><name><surname>Wasielewski</surname><given-names>B</given-names></name><name><surname>Meier</surname><given-names>C</given-names></name><name><surname>Prochnow</surname><given-names>N</given-names></name><name><surname>May</surname><given-names>C</given-names></name><name><surname>Galozzi</surname><given-names>S</given-names></name><name><surname>Marcus</surname><given-names>K</given-names></name><name><surname>Zoidl</surname><given-names>G</given-names></name><name><surname>Dermietzel</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Internal ribosomal entry site (IRES) activity generates endogenous carboxyl-terminal domains of Cx43 and is responsive to hypoxic conditions</article-title><source>The Journal of Biological Chemistry</source><volume>289</volume><fpage>20979</fpage><lpage>20990</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.540187</pub-id><pub-id pub-id-type="pmid">24872408</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wai</surname><given-names>T</given-names></name><name><surname>Langer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial Dynamics and Metabolic Regulation</article-title><source>Trends in Endocrinology and Metabolism</source><volume>27</volume><fpage>105</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2015.12.001</pub-id><pub-id pub-id-type="pmid">26754340</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Subramanian</surname><given-names>M</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Maxfield</surname><given-names>FR</given-names></name><name><surname>Tabas</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mitochondrial Fission Promotes the Continued Clearance of Apoptotic Cells by Macrophages</article-title><source>Cell</source><volume>171</volume><fpage>331</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.08.041</pub-id><pub-id pub-id-type="pmid">28942921</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>Miller</surname><given-names>C</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Sen</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mitochondrial connexin 43 in sex-dependent myocardial responses and estrogen-mediated cardiac protection following acute ischemia/reperfusion injury</article-title><source>Basic Research in Cardiology</source><volume>115</volume><elocation-id>e0759</elocation-id><pub-id pub-id-type="doi">10.1007/s00395-019-0759-5</pub-id><pub-id pub-id-type="pmid">31741053</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Shimura</surname><given-names>D</given-names></name><name><surname>Baum</surname><given-names>R</given-names></name><name><surname>Hernandez</surname><given-names>DM</given-names></name><name><surname>Agvanian</surname><given-names>S</given-names></name><name><surname>Nagaoka</surname><given-names>Y</given-names></name><name><surname>Katsumata</surname><given-names>M</given-names></name><name><surname>Lampe</surname><given-names>PD</given-names></name><name><surname>Kleber</surname><given-names>AG</given-names></name><name><surname>Hong</surname><given-names>T</given-names></name><name><surname>Shaw</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Auxiliary trafficking subunit GJA1-20k protects Connexin43 from degradation and limits ventricular arrhythmias</article-title><source>The Journal of Clinical Investigation</source><volume>130</volume><fpage>4858</fpage><lpage>4870</lpage><pub-id pub-id-type="doi">10.1172/JCI134682</pub-id><pub-id pub-id-type="pmid">32525845</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Furukawa</surname><given-names>K</given-names></name><name><surname>Hamasaki</surname><given-names>M</given-names></name><name><surname>Nezu</surname><given-names>A</given-names></name><name><surname>Otera</surname><given-names>H</given-names></name><name><surname>Saigusa</surname><given-names>T</given-names></name><name><surname>Yoshimori</surname><given-names>T</given-names></name><name><surname>Sakai</surname><given-names>Y</given-names></name><name><surname>Mihara</surname><given-names>K</given-names></name><name><surname>Kanki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial division occurs concurrently with autophagosome formation but independently of Drp1 during mitophagy</article-title><source>The Journal of Cell Biology</source><volume>215</volume><fpage>649</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1083/jcb.201605093</pub-id><pub-id pub-id-type="pmid">27903607</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youle</surname><given-names>RJ</given-names></name><name><surname>van der Bliek</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitochondrial fission, fusion, and stress</article-title><source>Science</source><volume>337</volume><fpage>1062</fpage><lpage>1065</lpage><pub-id pub-id-type="doi">10.1126/science.1219855</pub-id><pub-id pub-id-type="pmid">22936770</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Nuebel</surname><given-names>E</given-names></name><name><surname>Wisidagama</surname><given-names>DR</given-names></name><name><surname>Setoguchi</surname><given-names>K</given-names></name><name><surname>Hong</surname><given-names>JS</given-names></name><name><surname>Van Horn</surname><given-names>CM</given-names></name><name><surname>Imam</surname><given-names>SS</given-names></name><name><surname>Vergnes</surname><given-names>L</given-names></name><name><surname>Malone</surname><given-names>CS</given-names></name><name><surname>Koehler</surname><given-names>CM</given-names></name><name><surname>Teitell</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Measuring energy metabolism in cultured cells, including human pluripotent stem cells and differentiated cells</article-title><source>Nature Protocols</source><volume>7</volume><fpage>1068</fpage><lpage>1085</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.048</pub-id><pub-id pub-id-type="pmid">22576106</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6 J</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">#000664</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Gja1<sup>M213L/M213L</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib63">Xiao et al., 2020</xref> (DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI134682">10.1172/JCI134682</ext-link>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>AAV9</italic>)</td><td align="left" valign="bottom">AAV9-GST-GFP</td><td align="left" valign="bottom">Welgen Inc <xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref> (DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/jci.insight.121900">10.1172/jci.insight.121900</ext-link>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>AAV9</italic>)</td><td align="left" valign="bottom">AAV9-GJA1-20k-GFP</td><td align="left" valign="bottom">Welgen Inc <xref ref-type="bibr" rid="bib4">Basheer et al., 2018</xref> (DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/jci.insight.121900">10.1172/jci.insight.121900</ext-link>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Aenovirus</italic>)</td><td align="left" valign="bottom">GJA1-20k-V5</td><td align="left" valign="bottom">the CURE Vector Core <break/>Facility at University California, Los Angeles <break/><xref ref-type="bibr" rid="bib3">Basheer et al., 2017</xref> <break/>(DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCRESAHA.117.311955">10.1161/CIRCRESAHA.117.311955</ext-link>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Aenovirus</italic>)</td><td align="left" valign="bottom">GFP-V5</td><td align="left" valign="bottom">the CURE Vector Core Facility at University California, Los Angeles <xref ref-type="bibr" rid="bib3">Basheer et al., 2017</xref> (DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCRESAHA.117.311955">10.1161/CIRCRESAHA.117.311955</ext-link>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom">LOBSTR <italic>E. coli</italic> Expression Strain</td><td align="left" valign="bottom">kerafast <break/><xref ref-type="bibr" rid="bib1">Andersen et al., 2013</xref>; <break/><xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref> <break/>(DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/prot.24364">10.1002/prot.24364</ext-link>)</td><td align="left" valign="bottom">EC1001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo-sapiens</italic>)</td><td align="left" valign="bottom">HEK293FT</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">R70007</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (human)</td><td align="left" valign="bottom">siRNA to Gja1</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">ID HSS178257</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (human)</td><td align="left" valign="bottom">siRNA to DRP1</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">ID 19561</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (human)</td><td align="left" valign="bottom">siRNA to Dynamin 2</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">ID s4212</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Cx43-CT (Rabbit polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C6219</td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-DRP1 (Mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab56788</td><td align="left" valign="bottom">WB (1:500) ICC (1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-phospho-DRP1 at S616 (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="char" char="." valign="bottom">4,494 S</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-phospho-DRP1 at S616 (Rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="char" char="." valign="bottom">4,867 S</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-MFN1 (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="char" char="." valign="bottom">14,739 S</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-MFN2 (Mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab56889</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-MFN2 (Mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab56889</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-TOM20 (Mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">sc-17764</td><td align="left" valign="bottom">WB (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-TOM20 (Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab78547</td><td align="left" valign="bottom">ICC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Tubulin (Rat monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab6160</td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GFP (Chicken polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab13970</td><td align="left" valign="bottom">WB (1:10000) ICC (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-actin (Rabbit polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A2103</td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-COX IV (Mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab14744</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-MEK1/2 (Mouse monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="char" char="." valign="bottom">4,694 S</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pDEST-GJA1-20k-GFP (plasmid)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Fu et al., 2017</xref> (DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2017.00905">10.3389/fphys.2017.00905</ext-link>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">GFP version of <break/><ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/RRID:addgene_#49,861">Addgene_#49,861</ext-link></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pDEST-GST-GFP (plasmid)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Fu et al., 2017</xref> (DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2017.00905">10.3389/fphys.2017.00905</ext-link>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pDEST-LifeAct-mCherry (plasmid)</td><td align="left" valign="bottom">Addgene</td><td align="char" char="." valign="bottom">40,908</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pDEST-LifeAct-mCherry (plasmid)</td><td align="left" valign="bottom">Addgene</td><td align="char" char="." valign="bottom">40,908</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">mCherry-Drp1 (plasmid)</td><td align="left" valign="bottom">Addgene</td><td align="char" char="." valign="bottom">49,152</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pcDNA3-Drp1K38A (plasmid)</td><td align="left" valign="bottom">Addgene</td><td align="char" char="." valign="bottom">45,161</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequenced-based reagent</td><td align="left" valign="bottom">siRNA: Negative Control</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">12935300</td><td align="left" valign="bottom">Stealth RNAi</td></tr><tr><td align="left" valign="bottom">Sequenced-based reagent</td><td align="left" valign="bottom">Gja1_Fw</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GGGGACAAGTTTGTACAAAAAAGCAGGCTT<break/>CAGGAGGTATACATATGCATCATCATCATCAT<break/>CACGGTGGTGGCGGTTCAGGCGGAGGTGG<break/>CTCTGTTAAGGATCGGGTTAAGGGAAAG</td></tr><tr><td align="left" valign="bottom">Sequenced-based reagent</td><td align="left" valign="bottom">Gja1_Rv</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GGGGACCACTTTGTACAAGAAAGCTGGGTC<break/>TTACTAATCGTCATCATCGTCATCATCGTCATC<break/>ATCACTTCCACCACTTCCACCGATCT<break/>CCAGGTCATCAGGCCG</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">GJA1-20k</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">amino acids 236–382 of the full-length <break/>human Cx43, NCBI reference NP 000156,1</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">DC Protein Assay</td><td align="left" valign="bottom">Bio-Rad</td><td align="char" char="." valign="bottom">5000116</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Actin Polymerization Biochem Kit</td><td align="left" valign="bottom">Cytoskeleton, Inc</td><td align="left" valign="bottom">BK003</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Mouse Mitochondrial DNA Copy Number Assay kit</td><td align="left" valign="bottom">Detroit R&amp;D</td><td align="left" valign="bottom">NC1134958</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Human Mitochondrial DNA Monitoring Primer Set</td><td align="left" valign="bottom">TaKaRa Bio</td><td align="char" char="." valign="bottom">7,246</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Primary Cardiomyocyte Isolation Kit</td><td align="left" valign="bottom">Life Technologies</td><td align="char" char="." valign="bottom">88,281</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Mitochondria Isolation Kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">89,874</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ATPlite Luminescence Assay System</td><td align="left" valign="bottom">PerkinElmer</td><td align="char" char="." valign="bottom">6016943</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">HisPur Cobalt Purification Kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">PI-90092</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FuGene HD</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">E2312</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Lipofectamine RNAiMAX</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">13778150</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">mitochondrial division inhibitor 1</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">M0199</td><td align="left" valign="bottom">50 µM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Latrunculin A</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">L5163</td><td align="char" char="." valign="bottom">100 nM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Mitotracker Deep Red</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">m22426</td><td align="char" char="." valign="bottom">200 nM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Mitotracker Red CMXRos</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">M7512</td><td align="char" char="." valign="bottom">200 nM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TMRE</td><td align="left" valign="bottom">Cayman Chemical Company</td><td align="char" char="." valign="bottom">701,310</td><td align="char" char="." valign="bottom">200 nM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MitoSOX Red Mitochondrial Superoxide Indicator</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">M36008</td><td align="left" valign="bottom">5 µM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CellROX Deep Red</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">C10422</td><td align="left" valign="bottom">5 µM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ProLong Gold antifade regent with DAPI</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">P36935</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism 6.0</td><td align="left" valign="bottom">GraphPad Software Inc</td><td align="left" valign="bottom">Windows</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom">NIH</td><td align="left" valign="bottom">Windows</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Mitochondria morphology plugin</td><td align="left" valign="bottom">Dagda, Cherra et al. 2009 (DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M808515200">10.1074/jbc.M808515200</ext-link>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Chemidoc MP imaging system</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Image Lab software</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Adobe Photoshop</td><td align="left" valign="bottom">Adobe</td><td align="left" valign="bottom">Version 22.4.2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Adobe Illustrator</td><td align="left" valign="bottom">Adobe</td><td align="left" valign="bottom">Version 25.3.1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">triphenyl tetrazolium chloride (Stain)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">T8877</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">dihydroethidium (Stain)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">D23107</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69207.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Johnson</surname><given-names>Simon C</given-names></name><role>Reviewing Editor</role><aff><institution>University of Washington</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Mears</surname><given-names>Jason A</given-names></name><role>Reviewer</role><aff><institution>Case Western Reserve University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.05.05.442750">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.05.05.442750v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This study identifies a cardioprotective factor, GJA1-20k (a truncated form of Cx43), which appears to confer protection against ischemia/reperfusion (I/R) injury via promotion of mitochondrial fission. This finding is particularly interesting given that hyperfission is generally thought of as an index of toxicity in I/R or hypoxic injury. I/R lesion size in a GJA1 heterozygous mutant mouse is strikingly exacerbated compared to control animals, providing strong in vivo evidence supporting a role for this factor in protection from I/R.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Protective mitochondrial fission induced by stress responsive protein GJA1-20k&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Matt Kaeberlein as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Jason A Mears (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential Revisions</p><p>Mdivi-1 is has been shown to inhibit ETC CI as well as Drp1 (see &quot;The Putative Drp1 Inhibitor mdivi-1 Is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species&quot;). Changes to mitochondrial dynamics/structure may result from effects on ETC CI. Given the importance of Drp1 independence in the conclusions, the authors need to validate their findings using another method, such as overexpression of the dominant negative Drp1 mutant K38A.</p><p>K38A (or a similar approach) should also be used for the kinetic experiments.</p><p>The relative change in GJA1-20k expression in heterozygous (M213L/WT) animals should be shown, and the relative changes to ETC function (Seahorse) and mitochondrial size should be shown for the heterozygous animals. Some of this is already in supplemental, it should be presented in the main figures. This is important for interpreting the data in figure 5. The specificity of the phenotype to the stressed condition is striking, but because the phenotype is only shown in the heterozygotes (as homozygosity is lethal) the descriptive data in prior figures needs to show this setting.</p><p>The authors should show mitochondrial size post-I/R in control and heterozygous animals.</p><p>The H2O2 induced oxidative stress assay is not particularly informative or easy to interpret. I recommend moving this data to the supplement and focusing on additional endpoints from the mouse model in figure 5. The robustness of the phenotype in the I/R assay is much more compelling.</p><p>Mechanism of Drp1 independent fission is unclear – due to other GTPases such as dynamin-2?</p><p>The role of increased fission in protecting against ROS production thought to be a particularly interesting finding, but reviewers believe that mitochondria fragmented by Drp1 overexpression and suppression of Mfn1/2 or Opa1 is needed as an additional control.</p><p>To begin to address whether the fission/ROS findings from HEK293 cells are relevant to the in vivo results, the authors should be repeated in a more relevant cell type, such as in neonatal cardiomyocyte cells.</p><p>The authors should address the impact of GJA1-20k on mitochondrial membrane potential, ATP generating capacity, and rates of mitophagy.</p><p>GJA1-20k induces a clear difference in mitochondrial size, while total mitochondrial content appears unaltered (by Tom20). Previously it was suggested that mitochondrial biogenesis occurs with increased levels of GJA1-20k. Is this a difference in the cellular model, and do the changes in cell culture accurately recapitulate the changes seen in animals?</p><p>Please comment on the role of GJA1-20k in pathologic mitochondrial division during hypoxia/reoxygenation.</p><p>Please discuss the any perceived therapeutic implications of the findings.</p><p>Please discuss how altered mitochondrial size may alter cardiomyocyte and cardiac function. Is it possible that the benefits of GJA1-20K to infarct size come at a cost of cardiac function and reserve? Additional data to address this possibility would be helpful, but at minimum a discussion is needed.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>This group originally found that cardiomyocyte-specific overexpression of the Cx43 truncated isoform (GJA1-20k) protects the heart against ischemia/reperfusion injury in mice, and this study support their previous study by demonstrating the cardioprotective effect of GJA1-20k peptide administration. The authors suggest that Drp1-independent mitochondrial fission and ROS production precondition the heart against severe ischemic stress. This concept is very interesting and novel, but there are several concerns that should be revised.</p><p>1. The mechanism of how GJA1-20k induces Drp1-independent fission via actin accumulation to mitochondria is unclear. Please identify what drives the mitochondrial fission. Is it due to other GTPases such as dynamin-2 Nature 540, 139-143 (2016). https://doi.org/10.1038/nature20555?</p><p>2. The most important point is that GJA1-20k causes mitochondrial fission with few ROS production, and attenuates mitochondrial ROS production caused by hydrogen peroxide. To avoid the possibility of an artifact imaging, they need to carry out comparative experiments with cells that have fragmented mitochondria due to overexpression of Drp1 and suppression of Mfn1/2 or Opa1.</p><p>3. Most cell-level experiments use HEK293 cells, and it remains questionable whether they reflect in vivo cardiac results. Since the adenoviral gene transfer system into neonatal cardiomyocytes is performed in Figure 1, it is better to see the production of mitochondrial ROS in the same system (Figure 5E).</p><p>4. Does the GJA1-20k overexpression have impact on mitochondrial membrane potential and ATP-producing ability? Is mitochondria that are divided by GJA1-20k removed through mitophagy?</p><p>5. I would like you to clarify how much this GJA1-20k-dependent mitochondrial division contributes to pathological mitochondrial division under hypoxia /reoxygenation, which can be separated from Drp1-dependent mitochondrial fission. Figure 5—figure supplement 1 compares the mitochondria of WT and Gja1M213L / WT in the physiological state.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The following manuscript from Shimura et al., seeks to investigate the role of a 20kD protein isoform of Cx43 (GJA1-20k) in ischemic preconditioning. The authors discovered that GJA1-20K may provide protection in ischemic hearts through polymerizing actin around mitochondria and inducing mitochondrial fission. Through a series of elegant genetic, chemical, biochemical and cell biology studies including the use of the Gja1 M213L mouse line which was generated by this group, the authors determined that the salutatory effects of GJA1-20K was due to decreased reactive oxygen species (ROS) generation from smaller mitochondria. In general, the studies are a nice extension of published work from this group who initially discovered that a wide range of Cx43 protein isoforms can be generated from internal translation initiation sites within this protein. In particular, this study now further explores the specific role of GJA1-20K in the heart and discovered that it plays a critical role in ischemic preconditioning through affecting mitochondrial size and ROS production. Although the work is well done, there are some outstanding issues that the authors should address. It would be helpful if the authors discuss more the implication of the GJA1-20K isoform as therapy as the AAV9 work suggests the possibility of gene therapy in the future. It remains unclear as to how the authors envision such a scenario. Additional discussion would be helpful as to how smaller mitochondria from GJA1-20K over expression might impact cardiomyocyte and overall cardiac function, especially after ischemia or infarction. Although GJA1-20K may reduce infarct size, could this be at the expense of overall cardiac function or reserve?</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1. What are the levels of GJA1-20k over-expression in expts? Is it comparable to what has been described for endogenous increase observed with cardiomyocytes under stress?</p><p>2. Is there any difference when comparing mitochondria in the SSM and IFM? Are both populations affected?</p><p>3. The 20 kDa peptide contains some TM sequence, so why is it not targeted to the PM? Is there a MTS? A schematic earlier in the text would help orient the reader – similar to what has been shown in previous articles.</p><p>4. No change in S616 phosphorylation, but why not check S637? This site is thought to be the major driver of Drp1 activation/inactivation. So changes in the phosphorylation status at 637 is critical to provide a complete evaluation of Drp1 PTM regulation.</p><p>5. Is Drp1 localization altered when GJA1-20k is overexpressed? Hard to tell from Supplemental Figures No quantification.</p><p>6. In Figure 5, the Seahorse data show a higher level of non-mitochondrial respiration in the animal samples. This difference also mutes the differences in Basal Respiration, Leak and Maximal Respiration. There is definitely a trend in the data, but the differences are not as convincing if the non-mitochondrial respiration is taken into account (unless I am missing something in the way that the data is presented).</p><p>7. IMO, the discussion is a little long and winding. Some of it is necessary, but I think it can be more efficiently organized to better highlight the impact of your findings.</p><p>8. Typo in Line 45… &quot;stress sFriedman and&quot;.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69207.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>This group originally found that cardiomyocyte-specific overexpression of the Cx43 truncated isoform (GJA1-20k) protects the heart against ischemia/reperfusion injury in mice, and this study support their previous study by demonstrating the cardioprotective effect of GJA1-20k peptide administration. The authors suggest that Drp1-independent mitochondrial fission and ROS production precondition the heart against severe ischemic stress. This concept is very interesting and novel, but there are several concerns that should be revised.</p><p>1. The mechanism of how GJA1-20k induces Drp1-independent fission via actin accumulation to mitochondria is unclear. Please identify what drives the mitochondrial fission. Is it due to other GTPases such as dynamin-2 Nature 540, 139-143 (2016). https://doi.org/10.1038/nature20555?</p></disp-quote><p>We thank the Reviewer for raising this point and appreciate the novelty of introducing a type of mitochondrial fission that is independent of known mediators of fission. To address the Reviewer’s question and explore whether dynamin-2 (DNM2) is involved in the mitochondrial fission with GJA1-20k, for the revised manuscript we knocked-down DNM2 and assessed mitochondrial morphology with or without GJA1-20k. As seen in revised Figure 2—figure supplement 1 panels G–I, DNM2 knock-down does not significantly affect overall average area of mitochondria, with or without the presence of GJA1-20k. The failure of DNM2 knockdown to affect GJA1-20k mediated fission in the HEK cells we used, suggests that GJA1-20k activity on mitochondria can be independent of DNM2. Clearly there is still much to learn about GJA1-20k mediated fission. GJA1-20k is associated with the mitochondrial outer membrane (Basheer <italic>et al.</italic>, <italic>JCI Insight</italic>, 2018). While we should not rule out other mediators, we expect GJA1-20k is a direct binding partner and regulator of actin dynamics, as suggested by Figures 3D and 3E, and is therefore responsible for actin organization around mitochondrial bodies, inducing an actin mediated scission event (Figure 4).</p><p>The revised manuscript has been modified to include the above new data (Figure 2—figure supplement 1G–I) and discussion:</p><p>— Results section</p><p>“In addition to DRP1, Dynamin-2 (DNM2) is also a GTPase which can potentially regulate mitochondrial fission (Lee, Westrate et al., 2016). To explore possible DNM2 involvement, we knocked-down DNM2 by siRNA and analyzed mitochondrial morphology. In contrast to siDRP1, siDNM2 alone did not affect mitochondrial morphology (Figure 2—figure supplement 1G – I), with or without GJA1-20k, suggesting no involvement of DNM2 in mitochondrial dynamics of HEK293 cell lines. It has been reported that DNM2 is not necessary to be responsible for mitochondrial fission in other cell lines as well (Fonseca, Sanchez-Guerrero et al., 2019). The fact that DNM2 is not needed for GJA1-20k activity to occur, indicates it is not an essential co-factor in GJA1-20k mediated mitochondrial fission.”</p><p>—Discussion sections</p><p>“We have also investigated the involvement of DNM2 as another GTPase for the mitochondrial fission, but DNM2 knock-down failed to induce sufficient mitochondrial fusion or alter the effects of GJA1-20k (Figure 2 —figure supplement 1G–I). Therefore, it does not appear that DNM2 is essential for GJA1-20k activity on mitochondrial fission. In addition to actin, the endoplasmic reticulum (ER) membrane can be involved in mitochondrial scission (Friedman, Lackner et al., 2011, Tandler, Hoppel et al., 2018). Future studies should be considered whether GJA1-20k induced actin cytoskeleton arrangements involves ER membrane as well. Given the rapidity (less than one minute) of GJA1-20k induced fission, it is of interest how fission activity can be limited in stable cells, especially terminally differentiated cells such as adult cardiomyocytes.”</p><disp-quote content-type="editor-comment"><p>2. The most important point is that GJA1-20k causes mitochondrial fission with few ROS production, and attenuates mitochondrial ROS production caused by hydrogen peroxide. To avoid the possibility of an artifact imaging, they need to carry out comparative experiments with cells that have fragmented mitochondria due to overexpression of Drp1 and suppression of Mfn1/2 or Opa1.</p></disp-quote><p>We appreciate the Reviewer’s excellent suggestion. To address this concern, we overexpressed DRP1 and measured ROS production under H2O2 stress. As expected (and predicted by the Reviewer), DRP1 overexpression caused fragmented mitochondria (new Figure 5—figure supplement 1F, G). In addition, while H2O2 did not induce an increase in ROS production in the presence of GJA1-20k (new Figure 5—figure supplement 1D, E), H2O2 did induce an increase in ROS in the presence of DRP1 overexpression (new Figure 5—figure supplement 1 H, I). Therefore, mitochondrial fragmentation caused by DRP1 overexpression is more sensitive to oxidative stress and produces higher amount of ROS than in the presence of GJA1-20k. These data are supportive to our conclusion that GJA1-20k induces protective (rather than harmful) mitochondrial fission.</p><p>In addition, to add to the rigor of the study and address concerns about cardiac specificity, we performed new intact heart experiments revealing that there are larger mitochondria, more ROS, and larger areas of infarction in GJA1-20k insufficient mice subjected to I/R injury (Figure 5 E–L in the revised manuscript).</p><p>The revised manuscript has been modified to include the above new data (Figure 5E–L, and Figure 5—figure supplement 1) and discussion:</p><p>—Results section</p><p>“Given that GJA1-20k is a stress-responsive protein which can mediate ischemic preconditioning (Basheer, Fu et al., 2018) and to explore the protective effects of GJA1-20k against oxidative stress, we measured mitochondrial generation of reactive oxygen species (ROS) in HEK293 cells under oxidative stress induced by exogenous H2O2 treatment. In unstressed cells, the presence of GJA1-20k does not affect mitochondrial ROS generation (Figure 5—figure supplement 1D, E) whereas in the presence of exogenous H2O2, GJA1-20k prevents an increase in mitochondrial ROS (Figure 5—figure supplement 1D, E). Thus, GJA1-20k, which depresses mitochondrial respiration in unstressed cells, does not affect homeostatic ROS generation, yet has the beneficial effect of decreasing toxic ROS generation during stress (Figure 5A, B; Figure 5—figure supplement 1D, E). To clarify whether the protective effects come from GJA1-20k expression or mitochondrial size, we measured ROS from HEK293 cells with DRP1 overexpression instead of GJA1-20k overexpression. DRP1 overexpression decreased in mitochondrial size similar to GJA1-20k (Figure 5—figure supplement 1F, G). However, ROS generation induced by H2O2 was significantly increased and higher than GST control under H2O2 (Figure 5—figure supplement 1H, I). Taken together, GJA1-20k itself is necessary for the protective mitochondrial fission.”</p><p>—Discussion section</p><p>“DRP1-induced fission and smaller mitochondria are associated with excess ROS production, apoptosis, and organ injury (Hu, Huang et al., 2017, Wang, Subramanian et al., 2017), which is also seen in Figure 5 —figure supplement 1F–I, whereas DRP1-independent mitochondrial fission has been observed in cells undergoing protective mitophagy (Stavru, Palmer et al., 2013, Yamashita, Jin et al,. 2016, Coronado, Fajardo et al., 2018).”</p><p>—Discussion section</p><p>“Because GJA1-20k-induced fission is associated with less ROS production with oxidative stress (Figure 5 —figure supplement 1D, E), the endogenous generation of GJA1-20k and subsequent decreased ROS production could explain a major benefit of pre-conditioning. Of note, genetic GJA1-20k reduction increases infarct size and ROS production post-I/R injury (Figure 5E–H). In addition, the population of damaged mitochondria is significantly increased in heterozygous Gja1<sup>M213L/WT</sup> mouse heart post-I/R (Figure 5I–L). Therefore, GJA1-20k induced decreases in ROS production could limit the amount of I/R injury induced by myocardial infarction.”</p><disp-quote content-type="editor-comment"><p>3. Most cell-level experiments use HEK293 cells, and it remains questionable whether they reflect in vivo cardiac results. Since the adenoviral gene transfer system into neonatal cardiomyocytes is performed in Figure 1, it is better to see the production of mitochondrial ROS in the same system (Figure 5E).</p></disp-quote><p>This is an excellent comment from the Reviewer although we should emphasize, in the original Figure 1, we identified a consistent phenomenon of GJA1-20k induced mitochondrial reduction or GJA1-20k removal induced mitochondrial size increase in not just HEK293 cells, but neonatal cardiomyocytes, cardiomyocytes from the hearts of young adult mice as well as from the hearts of adult mice. With regard to mitochondrial ROS generation, isolated neonatal cardiomyocytes are notoriously difficult to induce mitochondrial ROS (Kang <italic>et al.</italic>, <italic>Circ Res.</italic>, 2000). Therefore, to address the Reviewer’s concern about physiological relevance, we used adult mouse heart tissue post-I/R injury and measured ROS production. As seen in new Figure 5 Panels G and H, adult heterozygous (Gja1<sup>M213L/WT</sup>) mouse hearts experience an increase in ROS production post-I/R injury compared to hearts from WT animals. Moreover, our previous study (Basheer <italic>et al.</italic>, <italic>JCI insight</italic>, 2018, Figure 7E, F) AAV9-transduced GJA1-20k overexpressed adult cardiomyocytes decreased ROS production. Taken together, the ROS measurements using HEK293 cells in the present manuscript are consistent with the new ex vivo adult heart results.</p><p>The revised manuscript has been modified to include the above new data (Figure 5G, H) and discussion:</p><p>—Results section</p><p>“However, remarkably, reduced GJA1-20k expression results in an almost complete cardiac infarction after I/R injury (Figure 5E, F). Moreover, ROS production after I/R injury was increased in Gja1<sup>M213L/WT</sup> mice compared to WT post-I/R (Figure 5G, H). There was no significant difference in mitochondria size at the basal condition between WT and Gja1<sup>M213L/WT</sup> mice adult CMs as with neonatal CMs (Figure 5I, J), whereas the mitochondria size was significantly increased after I/R injury and the heterozygous Gja1<sup>M213L/WT</sup> mice had larger mitochondria compared to WT mice post-I/R (Figure 5I, J). Interestingly, the area of mitochondrial matrix was also increased, suggesting loss of cristae in Gja1<sup>M213L/WT</sup> mice heart (Figure 5K, L). These data indicate that even partial deletion of GJA1-20k results in a profoundly impaired response to ischemic stress.”</p><p>—Discussion section</p><p>“Because GJA1-20k-induced fission is associated with less ROS production with oxidative stress (Figure 5 —figure supplement 1D, E), the endogenous generation of GJA1-20k and subsequent decreased ROS production could explain a major benefit of pre-conditioning. Of note, genetic GJA1-20k reduction increases infarct size and ROS production post-I/R injury (Figure 5E–H). In addition, the population of damaged mitochondria is significantly increased in heterozygous Gja1<sup>M213L/WT</sup> mouse heart post-I/R (Figure 5I–L). Therefore, GJA1-20k induced decreases in ROS production could limit the amount of I/R injury induced by myocardial infarction.”</p><disp-quote content-type="editor-comment"><p>4. Does the GJA1-20k overexpression have impact on mitochondrial membrane potential and ATP-producing ability? Is mitochondria that are divided by GJA1-20k removed through mitophagy?</p></disp-quote><p>We appreciate the Reviewer’s excellent suggestions. To address these concerns, we analyzed mitochondrial membrane potential (measured by TMRE intensity), ATP production, and mitophagy (measured by LC3 intensity). As seen new Figure 1—figure supplement 2, GJA1-20k expression, or its homozygous removal, does not alter membrane potential, ATP production, or mitophagy.</p><p>The revised manuscript has been modified to include the above new data (Figure 1—figure supplement 2) and discussion:</p><p>—Results section</p><p>“Previously we reported that GJA1-20k is involved in mitochondrial biogenesis (Basheer, Fu et al., 2018). Consistent with our previous study, AAV9-transduced adult cardiomyocytes showed increased mitochondrial DNA copy number and GJA1-20k deficient mice (Gja1M213L/M213L) had decreased copy number. However, exogenous GJA1-20k did not alter the mitochondrial biogenesis in HEK293 cells. Nor did exogenous GJA1-20k affect membrane potential or baseline ATP production (Figure 1—figure supplement 2A–C). In addition to mitochondrial DNA copy number, neither biogenesis nor mitophagy protein markers were altered in either GJA1-20k transfected HEK293 cells or Gja1<sup>M213L/M213L</sup> mouse hearts (Figure 1—figure supplement 2D – G).</p><p>—Discussion section</p><p>“Yet the presence of GJA1-20k, while inducing mitochondrial fission and smaller mitochondria (Figure 1, 3 and 4), does not either reduce MFN1 or MFN2, activate DRP1, change membrane potential, ATP production, mitochondrial biogenesis, or mitophagy (Figure 2; Figure 1 —figure supplement 2).”</p><disp-quote content-type="editor-comment"><p>5. I would like you to clarify how much this GJA1-20k-dependent mitochondrial division contributes to pathological mitochondrial division under hypoxia /reoxygenation, which can be separated from Drp1-dependent mitochondrial fission. Figure 5—figure supplement 1 compares the mitochondria of WT and Gja1M213L / WT in the physiological state.</p></disp-quote><p>We appreciate the Reviewer’s excellent suggestion. In the same protocol for response to point #3 above, we subjected adult WT and Gja1<sup>M213L/WT</sup> hearts to ex-vivo I/R injury and then used electron microscopy to assess mitochondrial differences. Consistent with previous studies (Allen <italic>et al.</italic>, <italic>Commun Biol</italic>, 2020), acute I/R injury caused mitochondrial swelling in both WT and Gja<sup>M213L/WT</sup> hearts. However, Gja1<sup>M213L/WT</sup> hearts had a greater increase in mitochondrial swelling compared to WT post-I/R (Figure 5I, J). Furthermore, Gja1<sup>M213L/WT</sup> hearts had increased mitochondria matrix area (i.e. less cristae), indicating additional fragility of mitochondria from Gja1<sup>M231L/WT</sup> hearts (Figure 5I, K, and L). These data are supportive of the previous TTC staining results (Figure 5E, F), a necessity of GJA1-20k for cardioprotection against acute I/R injury.</p><p>The revised manuscript has been modified to include the above new data (Figure 5I–L) and discussion:</p><p>—Results section</p><p>“There was no significant difference in mitochondria size at the basal condition between WT and Gja1<sup>M213L/WT</sup> mice adult CMs as with neonatal CMs (Figure 5I, J), whereas the mitochondria size was significantly increased after I/R injury and the heterozygous Gja1<sup>M213L/WT</sup> mice had larger mitochondria compared to WT mice post-I/R (Figure 5I, J). Interestingly, the area of mitochondrial matrix was also increased, suggesting loss of cristae in Gja1<sup>M213L/WT</sup> mice heart (Figure 5K, L). These data indicate that even partial deletion of GJA1-20k results in a profoundly impaired response to ischemic stress.”</p><p>—Discussion section</p><p>“Because GJA1-20k-induced fission is associated with less ROS production with oxidative stress (Figure 5 —figure supplement 1D, E), the endogenous generation of GJA1-20k and subsequent decreased ROS production could explain a major benefit of pre-conditioning. Of note, genetic GJA1-20k reduction increases infarct size and ROS production post-I/R injury (Figure 5E–H). In addition, the population of damaged mitochondria is significantly increased in heterozygous Gja1<sup>M213L/WT</sup> mouse heart post-I/R (Figure 5I–L). Therefore, GJA1-20k induced decreases in ROS production could limit the amount of I/R injury induced by myocardial infarction.”</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The following manuscript from Shimura et al., seeks to investigate the role of a 20kD protein isoform of Cx43 (GJA1-20k) in ischemic preconditioning. The authors discovered that GJA1-20K may provide protection in ischemic hearts through polymerizing actin around mitochondria and inducing mitochondrial fission. Through a series of elegant genetic, chemical, biochemical and cell biology studies including the use of the Gja1 M213L mouse line which was generated by this group, the authors determined that the salutatory effects of GJA1-20K was due to decreased reactive oxygen species (ROS) generation from smaller mitochondria. In general, the studies are a nice extension of published work from this group who initially discovered that a wide range of Cx43 protein isoforms can be generated from internal translation initiation sites within this protein. In particular, this study now further explores the specific role of GJA1-20K in the heart and discovered that it plays a critical role in ischemic preconditioning through affecting mitochondrial size and ROS production. Although the work is well done, there are some outstanding issues that the authors should address. It would be helpful if the authors discuss more the implication of the GJA1-20K isoform as therapy as the AAV9 work suggests the possibility of gene therapy in the future. It remains unclear as to how the authors envision such a scenario.</p></disp-quote><p>We agree with the Reviewer that AAV9 mediated cardioprotection of anticipated ischemia would be the natural extension of our work. In addition, gene delivery to other ischemia sensitive organs such as the kidneys and brain should be considered. There is also the possibility of delivery of GJA1-20k peptide acutely. In unpublished preliminary studies, we have found that GJA1-20k peptide in culture is able to cross the cell membrane, enter cells and increase the cells’ resistance to oxidative and fluorescent damage. Furthermore, in a large animal (porcine) model of hypovolemic shock, we have found that intravenous injection of GJA1-20k protects against experimentally induced cardiac ischemia. The revised manuscript has been modified to include this discussion:</p><p>—Discussion section</p><p>“Major cardiovascular procedures are associated with low flow and ischemia related damage to end-organs such as the heart, kidneys, and brain. A priori gene therapy mediated delivery of GJA1-20k to these organs could be beneficial. For instance, percutaneous coronary interventions are associated with both cardiac and renal damage (Brown, Malenka et al., 2008, Tricoci, Newby et al., 2018) and could benefit from GJA1-20k induced protection. Similarly, coronary bypass surgery with cardiopulmonary bypass is associated with low flow damage to the brain and kidneys (Roach, Kanchuger et al., 1996, McKhann, Grega et al., 2006, O'Neal, Shaw et al., 2016), and abdominal aorta surgery is associated with renal damage, all of which may benefit from viral mediated GJA1-20k pretreatment.</p><p>It is also possible, as suggested by unpublished preliminary studies by our group, that GJA1-20k peptide administration intravenously can gain access to the intracellular environments of the heart and other organs. In this scenario, GJA1-20k administration could occur minutes to hours ahead of an ischemic insult rather than the presumably days to weeks which would be needed for viral mediated introduction. Future studies will focus on acute intravenous administration of GJA1-20k peptide in subjects about to undergo anticipated ischemia.”</p><disp-quote content-type="editor-comment"><p>Additional discussion would be helpful as to how smaller mitochondria from GJA1-20K over expression might impact cardiomyocyte and overall cardiac function, especially after ischemia or infarction. Although GJA1-20K may reduce infarct size, could this be at the expense of overall cardiac function or reserve?</p></disp-quote><p>Neither viral mediated overexpression of GJA1-20k or development of a mouse line that reduces internal translation initiation of GJA1-20k results in a significant change in cardiac function (Basheer <italic>et al.</italic>, <italic>JCI insight</italic>, 2018; Xiao <italic>et al.</italic>, <italic>J Clin Invest</italic>, 2020). However, as the Reviewer suggests, acute administration of higher dose of GJA1-20k could still possibly result in decreased function. In fact, as we have found earlier (Basheer <italic>et al.</italic>, <italic>JCI insight</italic>, 2018), GJA1-20k is stress responsive and may mediate post-ischemic cardiac stunning which is typified by viable but poorly functioning myocardium post-ischemic insult. The revised manuscript has been modified to include this discussion:</p><p>—Discussion section</p><p>“We have found that neither exogenous GJA1-20k overexpression in mouse hearts nor GJA1-20kM213L/WT adult mice have altered unstressed cardiac function (Basheer, Fu et al., 2018, Xiao, Shimura et al., 2020). However acute administration of GJA1-20k or using GJA1-20k in the context of stressed myocardium could conceivably result in diminished cardiac function. As GJA1-20k is stress responsive, an increase in GJA1-20k may be a mediator of post-ischemic protection (Basheer, Fu et al., 2018), and even responsible for the phenomenon of myocardial stunning which happens to be associated with small mitochondria (Borgers, Thone et al., 1993, Borgers 2002). On the other hand, GJA1-20k induced functional hibernation of stressed myocardium, while increasing survival, could conceivably result in diminished cardiac function. If indeed GJA1-20k induces an acute cardiac depressant response, appropriate steps would be needed to compensate for lower cardiac output during the myocardial protection period.”</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>1. What are the levels of GJA1-20k over-expression in expts? Is it comparable to what has been described for endogenous increase observed with cardiomyocytes under stress?</p></disp-quote><p>We appreciate Reviewer #3’s valuable question. In the present study, the exogenous plasmid transfection expresses approximately 5.6-fold increased GJA1-20k compared to endogenous (See <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref> ). Our previous study revealed about 1.5-fold, 6.0-fold, and 2.0-fold increased GJA1-20k expression in mouse I/R injury, mouse subacute ischemic cardiomyopathy, and human end-stage ischemic cardiomyopathy, respectively (Figure 1 and 2 in Basheer <italic>et al.</italic>, <italic>JCI insight</italic>, 2018). Therefore, our cell line data is applicable for the GJA1-20k overexpression study, especially for acute effects.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>The quantification of exogenous GJA1-20k expression in HEK293 cells.</title><p>(A) Representative Western blot membrane image from GFP-tagged GJA1-20k transfected cells. (B and C) The quantification of band intensity between endogenous and exogenous GJA1-20k. The graphs were expressed as mean ± SD.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69207-sa2-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>2. Is there any difference when comparing mitochondria in the SSM and IFM? Are both populations affected?</p></disp-quote><p>We thank the Reviewer for this excellent question. On reviewing our EM data, we do not have the resolution or immunogold imaging of the older highly organized mouse hearts to permit accurate quantitative comparison between SSM and IFM mitochondria. This is an important question that we should follow-up for a future careful study dedicated to this issue, and appreciate the Reviewer’s insight in pointing out this direction.</p><disp-quote content-type="editor-comment"><p>3. The 20 kDa peptide contains some TM sequence, so why is it not targeted to the PM? Is there a MTS? A schematic earlier in the text would help orient the reader – similar to what has been shown in previous articles.</p></disp-quote><p>We appreciate this important question from the Reviewer. By an in silico search, we could not identify a MTS in GJA1-20k. There are reports that Hsp90 helps target Cx43 to mitochondrial membrane (Rodriguez-Sinovas <italic>et al.</italic>, <italic>Circ Res.</italic>, 2006; and Rodriguez-Sinovas <italic>et al.</italic>, <italic>Biochim Biophys Acta Biomem.</italic>, 2018), which would be consistent with GJA-20k localizing to mitochondria during stress. As we have emphasized earlier, prior reports of Cx43 localization by immunocytochemistry may actually have identified GJA1-20k rather than full length Cx43 since the epitope of most anti-Cx43 antibodies is on the C-terminus and will identify GJA1-20k as well. Because GJA1-20k is hydrophilic and does not exist as membrane bound hexamers like Cx43, GJA1-20k does not require vesicle based delivery to the plasma membrane, and therefore is more available for attachment to intracellular organelles such as mitochondria.</p><p>We apologize, but need clarification on the Reviewer’s request for a schematic earlier in the text. Should our overall schematic (Figure 6 in the revised manuscript) appear earlier or does the Reviewer suggest a GJA1-20k specific explanatory schematic and/or sequence that is introduced earlier on so readers can differentiate GJA1-20k from full length Cx43 hemichannels?</p><disp-quote content-type="editor-comment"><p>4. No change in S616 phosphorylation, but why not check S637? This site is thought to be the major driver of Drp1 activation/inactivation. So changes in the phosphorylation status at 637 is critical to provide a complete evaluation of Drp1 PTM regulation.</p></disp-quote><p>We appreciate Reviewer #3’s thoughtful comment. We additionally analyzed phospho-DRP1 (S637) expression and found no change in the expression (Figure 2 A, B in revised manuscript).</p><p>The revised manuscript has been modified to include the above new data (Figure 2A, B):</p><p>—Results section</p><p>“DRP1 is potentiated by phosphorylation of its Serine 616 and 637 (Sabouny and Shutt 2020). We tested abundance of total DRP1 and phosphorylated DRP1 in GJA1-20k transfected HEK293 cells and found no significant difference in either the protein levels of total DRP1, DRP1-pS616, -pS637, or in the ratio (pS616/total) (Figure 2A, B). The levels of MFN1 and MFN2, and mitochondrial marker protein TOM20, a marker of cellular mitochondrial content, were also unchanged (Figure 2A, B).”</p><disp-quote content-type="editor-comment"><p>5. Is Drp1 localization altered when GJA1-20k is overexpressed? Hard to tell from Supplemental Figures No quantification.</p></disp-quote><p>We appreciate Reviewer #3’s valuable question. To address this issue, we quantified amount of mitochondria associated with DRP1. As shown in Figure 2—figure supplement 1C, there was no significant difference in DRP1 localization to mitochondria between GST control and GJA1-20k transfected group.</p><p>The revised manuscript has been modified to include the above new data (Figure 2—figure supplement 1C).</p><disp-quote content-type="editor-comment"><p>6. In Figure 5, the Seahorse data show a higher level of non-mitochondrial respiration in the animal samples. This difference also mutes the differences in Basal Respiration, Leak and Maximal Respiration. There is definitely a trend in the data, but the differences are not as convincing if the non-mitochondrial respiration is taken into account (unless I am missing something in the way that the data is presented).</p></disp-quote><p>We would like to thank Reviewer #3 for pointing this out. As the reviewer indicates, non-mitochondrial respiration is increased in GJA1 mutant mouse hearts. In the revised manuscript we provide bar graphs indicating each OCR parameter (Figure 5 —figure supplement 1C). To calculate these parameters, non-mitochondrial respiration (third measurement point of R/A treatment) was subtracted. The data confirm maximal respiration is increased in the Gja1<sup>M213L/M213L</sup> mice.</p><p>To clarify this point, we have updated the Methods section:</p><p>—Methods section</p><p>“For basal respiration, we calculated the difference between the third measurement during the pre-oligomycin phase and the third measurement post-R/A. For proton leak, we calculated the difference between the third measurement during the post-oligomycin and the third measurement post-R/A. For maximum respiration, we calculated the difference between the third measurement during the post-FCCP and the third measurement post-R/A. For ATP-linked respiration, we calculated the difference between the third measurement during the pre-oligomycin phase and the third measurement post-oligomycin. For reserve capacity, we calculated the difference between the third measurement during the post-FCCP and the third measurement the pre-oligomycin phase. For non-mitochondrial respiration, we used the value at the third measurement post-R/A.”</p><p>Also, the revised manuscript has been modified to include the above new data (Figure 5C, D; Figure 5—figure supplement 1A, B):</p><p>—Results section</p><p>“Similarly, maximal respiration is increased in neonatal CMs derived from GJA1-20k deficient Gja1<sup>M213L/M213L</sup> mice and maximal respiration for heterozygous Gja1<sup>M213L/WT</sup> mice is between that of WT and Gja1<sup>M213L/M213L</sup> (Figure 5C, D; Figure 5—figure supplement 1A, B). In addition, observing other OCR parameters, we found a decrease in ATP-linked respiration and reserve capacity in Gja1<sup>M213L/WT</sup> cardiomyocytes, and an increase in proton leak and non-mitochondrial respiration in Gja1<sup>M213L/M213L</sup> suggesting that there can be compensatory long-term effects of the Gja1 mutation (Figure 5—figure supplement 1C).”</p><disp-quote content-type="editor-comment"><p>7. IMO, the discussion is a little long and winding. Some of it is necessary, but I think it can be more efficiently organized to better highlight the impact of your findings.</p></disp-quote><p>We appreciate Reviewer #3’s thoughtful comment. In the original manuscript and especially in the revised manuscript we have included text to address potential questions from a diversity of readers, from cytoskeleton dynamics to ischemic preconditioning. We have attempted to still make the Discussion coherent but do not was to be too pithy at the expense of addressing an issue important to a particular Reviewer or reader.</p><disp-quote content-type="editor-comment"><p>8. Typo in Line 45… &quot;stress sFriedman and&quot;.</p></disp-quote><p>We thank the reviewer for pointing this out. We corrected the typo.</p></body></sub-article></article>